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 Linker histone H1 is a key structural protein facilitating the formation of higher 
order chromatin structures and regulates specific gene expression.  In mammals, there 
exist 11 closely related H1 variants.  Previous studies show that H1 depletion by 50% 
impairs specific gene regulation and differentiation of embryonic stem cells (ESCs).  
However, the mechanisms by which H1 and its variants regulate ESC differentiation 
remain elusive.  Here, we demonstrate a dosage effect of H1 variants in mouse ESCs 
through severe H1 depletion and mutation analysis.  We establish ultra-low H1 ESCs by 
sequential depletion of six somatic H1 variants.  These cells exhibit normal ESC 
morphology and self-renewal.  During neural differentiation, the total H1 level gradually 
increases, and H1 depletion reveals a dosage effect in neurite formation, induction of 
neural lineage-specific genes, and silencing of pluripotency-associated genes such as 
Oct4 and Nanog.  In addition, severe H1 depletion causes reduced cell proliferation and 
cellular senescence in neural lineages.  Significantly, Oct4 knockdown effectively 
restores neural differentiation and partially rescues the reduction in cell proliferation and 
cellular senescence.  These results suggest that H1 is crucial for neural differentiation of 
ESCs and its regulation in the process acts in a dosage dependent, rather than a variant 
specific, manner.  
Another part of this thesis centers on analysis of H1 mutations frequently 
occurred in follicular lymphoma or transformed follicular lymphoma.  These mutations in 
H1 are clustered in the globular and C-terminal domains directly involved in chromatin 







 expressed in H1c/H1d/H1e triple knockout mouse ESCs, we find that S102F 
mutation dramatically impairs the association of hH1c with chromatin.  These results 
suggest that the identified H1 mutations in follicular lymphoma most likely result in a 
loss-of-function phenotype by reducing the binding affinity of H1 for chromatin, thus 
















1.1 Linker Histone H1 Family 
 
In eukaryotic nuclei, DNA is packaged into chromatin by binding to histone 
proteins, a family of positively charged proteins, including H1, H2A, H2B, H3, and H4.  
The fundamental repeating unit of chromatin is the nucleosome (van Holde, 1988; Wolffe 
and Kurumizaka, 1998), which consists of about 147 base pairs of DNA wrapped 
approximately 1.7 turns around a core histone octamer (Davey et al., 2002; Luger et al., 
1997).  The DNA between nucleosomes is called “linker DNA”, which together with 
nucleosome core particles form the extended chromatin fiber, the 10 nm “beads-on-a-
string” fiber observed under the electron microscope (Olins and Olins, 1974; Woodcock 
et al., 1976).  The linker histone H1 seals the nucleosomes at the entry and exit sites of 
DNA to stabilize the nucleosomes and facilitate the folding of the 30 nm chromatin fiber 
(Ramakrishnan, 1997; Thoma et al., 1979; Wolffe, 1997).   
All metazoan histone H1s share a generic tri-partite structure consisting of a short, 
flexible N-terminal tail, a highly conserved globular domain with a winged-helix motif, 
and a long extended lysine rich C-terminal tail (Allan et al., 1980; Chapman et al., 1976; 
Ramakrishnan et al., 1993).  The structure of H1s from unicellular eukaryotes, yeast and 
Tetrahymena, however, is rather different from metazoan H1s.  Tetrahymena H1 lacks 
the most conserved globular domain found in multicellular organisms (Brown and 
Sittman, 1993; Wolffe, 1997; Wu et al., 1986), whereas the yeast H1, Hho1, consists of 





domain of H1 is highly conserved and necessary for interaction with nucleosomal DNA 
(Brown et al., 2006).  Both the globular and the C-terminal domains are involved in high 
affinity binding of H1 to chromatin (Brown et al., 2006; Hendzel et al., 2004; Stasevich 
et al., 2010; Syed et al., 2010).  In vivo studies using H1-GFP fusion proteins and FRAP 
(Fluorescence Recovery after Photobleaching) assays show that the binding of H1 to 
chromatin is dynamic with a rapid exchange rate (Lever et al., 2000; Misteli et al., 2000).  
The H1 histone family is the most divergent and heterogeneous group of histones 
among the highly conserved histone protein families.  In mammals, as many as 11 closely 
related nonallelic H1 variants have been characterized, including 7 somatic H1s (H1a, 
H1b, H1c, H1d, H1e, H1
0
, and H1x), 3 testicular H1s (H1t, H1T2, and HILS1), and one 
oocyte-specific H1 (H1oo) (Happel and Doenecke, 2009) (Figure 1.1).  Each H1 variant 
is encoded by a single copy gene.  While H1a-e are replication-dependent, mainly 
expressed in the S phase of the cell cycle, the replacement histone H1
0
 is replication-
independent, enriched in terminally differentiated cell types that have stopped dividing 
(Izzo et al., 2008; Khochbin, 2001; Sekeri-Pataryas and Sourlingas, 2007; Zlatanova and 
Doenecke, 1994).  The mRNA messages of replication-dependent H1 genes lack introns 
and a poly-A tail, but possess a stem-loop sequence at the 3’ end instead, and their 
proteins are mainly synthesized during S phase (Dominski and Marzluff, 1999).  The 
replication-dependent H1a-e and H1t genes are clustered together with multiple core 
histone genes on human chromosome 6 and murine chromosome 13, whereas other H1 
genes are scattered in the genome and expressed as polyadenylated mRNA messages 
throughout cell cycle independent of DNA replication.  The most newly characterized 





other H1 variants (Happel et al., 2005; Yamamoto and Horikoshi, 1996).  The expression 
of H1 variants is tightly regulated in development and cellular differentiation, and their 
composition differs in different tissues (Fan et al., 2003; Wang et al., 1997; Woodcock et 
al., 2006; Zhang et al., 2012).  For example, while H1
0
 and H1e are the major H1 variants 
in adult mouse liver, constituting ~30% and ~40% of total H1 respectively, these two 
variants only account for approximately 2% and 10% of total H1 in mouse thymus (Fan 

























H1c   M-----SEAAPAAP--AAAPPAEKAPAKKKAAKK--PAGVRRKASGPPVSELITKAVAASKERSGVSLA-ALKKALAAA 69 
H1d   M-----SETAPAAP--AAPAPVEKTPVKKKAKKTG-AAAGKRKASGPPVSELITKAVAASKERSGVSLA-ALKKALAAA 70 
H1e   M-----SETAPAAP--AAPAPAEKTPVKKKARKA--AGGAKRKTSGPPVSELITKAVAASKERSGVSLA-ALKKALAAA 69 
H1b   M-----SETAPAET--AAPAPVEKSPAKKKTTKK--AGAAKRKATGPPVSELITKAVSASKERGGVSLP-ALKKALAAG 69 
H1a   M-----SETAPVAQ--AASTATEKPAAAKKTKKPAKAAAPRKKPAGPSVSELIVQAVSSSKERSGVSLA-ALKKSLAAA 71 
H1t   M-----SETAPAASSTLVPAPVEEKPSSKRRGKKP-GLAPARKPRGFSVSKLIPEALSTSQERAGMSLA-ALKKALAAA 72 
H10   M-----TENSTSAP-----------AAKPKRAKAS-----KKSTDHPKYSDMIVAAIQAEKNRAGSSRQ-SIQKYIKSH 57 
H1x   M-SVELEEALPPTSADGTARKTAKAGGSAAPTQPK-RRKNRKKNQPGKYSQLVVETIRKLGERGGSSLARIYAEARKVA 77 
H1oo  MAPGSVSSVSSSSFPSRDTSPSGSCGLPGADKPGPSCRRIQAGQRNPTMLHMVLEALKAREARQGTSVV-AIKVYIQHK 78 
H1t2  M-----AEAVQPSG--ESQGAELTIQIQQPAERALRTPAKRGTQSVLRVSQLLLRAIAG---HQHLTLD-ALKKELGNA 68 
HILS1 M-----AQMVAGDQ------DAGTLWVPSQSESQTESDISTQSLRKPTMSYVILKTLADKRVHNCVSLA-TLKKAVSIT 67 
 
   
     
H1c   GYDVEKN--NSRIKLGLKSLVSKGILVQ---TKGTGASGSFKLNKKAASGEAKPQAKKAGAAKAKKPAGAAKKPKKATG 143 
H1d   GYDVEKN--NSRIKLGLKSLVSKGTLVQ---TKGTGASGSFKLNKKAASGEAKPKAKKAGAAKAKKPAGAAKKPKKATG 144 
H1e   GYDVEKN--NSRIKLGLKSLVSKGTLVQ---TKGTGASGSFKLNKKAASGEAKPKAKRAGAAKAKKPAGAAKKPKKAAG 143 
H1b   GYDVEKN--NSRIKLGLKSLVSKGTLVQ---TKGTGASGSFKLNKKAASGEAKPKAKKTGAAKAKKPAGAT--PKKPKK 141 
H1a   GYDVEKN--NSRIKLGLKSLVNKGTLVQ---TKGTGAAGSFKLNKKAES-----KAITTKVSVKAKASGAAKKPKKTAG 140 
H1t   GYDVEKN--NSRIKLALKRLVNKGVLVQ---TKGTGASGSFKLSKKAASGNDKGKGKKSASAKAKK--------MGLPR 138 
H10   YKVGENA--DSQIKLSIKRLVTTGVLKQ---TKGVGASGSFRLAKGDEPKRSVAFKKTKKEVKKVATPKKAAKPKKAAS 131 
H1x   WFDQQNG--RTYLKYSIRALVQNDTLLQ---VKGTGANGSFKLNRKKLEGGAERRGASAASSPAPKAR------TAAAD 145 
H1oo  YPTVDTTRFKYLLKQALETGVRRGLLTRPAHSKAKGATGSFKLVPKPKTKKACAPKAGRGAAGAKETGSKKSGLLKKDQ 157 
H1t2  GYEVRRE--ISSHHEGKSTRLEKGTLLR---VSGSDAAGYFRVWKISKPREKAGQSRLTLGSHSSGKTVLKSPRPLRPR 142 




H1c   AATPKKAAKKTPKKAKKPAAAAVTKKVAKSPKKAK-VTKPK-------KVKS-ASKAVKP-----KAAKPK-VAKAKKV 207 
H1d   AATPKKTAKKTPKKAKKPAAAAGAKKVSKSPKKVK-AAKPKKAAKSPAKAKAPKAKASKP-----KASKPK-ATKAKKA 216 
H1e   TATAKKSTKKTPKKAKKPAAAAGAKKA-KSPKKAK-ATKAKKAPKSPAKAKTVKPKAAKP-----KTSKPK-AAKPKKT 214 
H1b   TAGAKKTVKKTPKKAKKPAAAG-VKKVAKSPKKAKAAAKPKKAAKSPAKPKAVKSKASKPKVTKPKTAKPK-AAKAKKA 218 
H1a   -AAAKKTVK-TPKKPKKPAVSK---KTSKSPKKPK-VVKAKKVAKSPAKAKAVKPKASKA-----KVTKPKTPAKPKKA 208 
H1t   ASRSPKSSK--TKAVKKPKATP--TKASGSGRKTK-GAKGVQQRKSPAKARAANPNSGKA-----KMVMQK--TDLRKA 205 
H10   KAPSKKPKATPVKKAKK--------KPAATPKKAK--------KPKVVKVKPVKASKPKK----AKTVKPKAKSSAKRA 190 
H1x   RTPARPQPERRAHKSKK-------AAAAASAKKVK-------------K-------AAKP-------------SVPKVP 184 
H1oo  VGKATMEKGQKRRAYPCKAATLEMAPKKAKAKPKEVRKAPLKQDKAAGAPLTANGGQKVKRSGSRQEANAHGKTKGEKS 236 
H1t2  SRRKAAKKAREVWRRKARALKARSRRVRTRSTSGARSRTRSRASSRATSRATSRARSRARSRAQSSARSSARSSAKSSA 221 




H1c   AAKKK-------------------------------------------------------------------------- 212 
H1d   APRKK-------------------------------------------------------------------------- 221 
H1e   AAKKK-------------------------------------------------------------------------- 219 
H1b   VSKKK-------------------------------------------------------------------------- 223 
H1a   APKKK-------------------------------------------------------------------------- 213 
H1t   AGRK--------------------------------------------------------------------------- 209 
H10   SKKK--------------------------------------------------------------------------- 194 
H1x   KGRK--------------------------------------------------------------------------- 188 
H1oo  KPLASKVQNSVASLAKRKMADMAHTVTVVQGAETVQETKVPTPSQDIGHKVQPIPRVRKAKTPENTQA----------- 304 
H1t2  KSSTRSSAKSWARSKARSRARSRAKDLVRSKAREQAQAREQARARAREQAHARARTQDWVRAKAQEFVSAKEQQYVRAK 300 








H1t2  KACTKSFTKSGQPGDTESP------------------------------------------------------------ 398 
The black line on top of amino acid sequences marks the globular domain. Conversed 





1.2 Histone H1 Depletion in Protists and Metazoans 
 
Depletion of specific H1 variants has been performed in various protists and 
metazoans (Figure 1.2).  The complete H1 elimination in protozoans such as 
Saccharomyces cerevisiae (Patterton et al., 1998), Tetrahymena theromophila (Shen et al., 
1995), Aspergillus nidulans (Ramon et al., 2000), Ascobolus immersus (Barra et al., 
2000), doesn’t affect growth and viability, but it gives rise to distinct phenotypes.  H1 
deletion in Tetrahymena leads to enlarged nuclei (Shen and Gorovsky, 1996).  Up- or 
down- regulation of specific genes is also observed in Tetrahymena (Shen and Gorovsky, 
1996) and yeast (Hellauer et al., 2001) with H1 deletion, suggesting that linker histone 
H1 is a fine-tuner of specific genes rather than a global transcriptional regulator in 
unicellular organisms.  Loss of H1 in Ascobolus immersus causes an abrupt stop of 
growth and increased accessibility of micrococcal nuclease to chromatin, indicating that 
H1 is necessary for long life span and chromatin organization (Barra et al., 2000).  
Similarly, another study finds that loss of the yeast H1 homolog, Hho1p, results in 
shortened life span in Saccharomyces cerevisiae, likely owing to a role of histone H1 in 
DNA repair by inhibiting homologous recombination (Downs et al., 2003).  These 
findings indicate that, although histone H1 is not essential for survival of protists, it may 



























In contrast to unicellular organisms, metazoans generally have multiple histone 
H1 variants, elimination of which gives rise to diverse phenotypes (Figure 1.2).  
Caenorhabditis elegans has eight H1 isoforms.  HIS-24 (an ortholog of mammalian 
HIST1H1A) depletion leads to severe abnormalities in germline proliferation and 
differentiation of hermaphrodites, as well as changes in H3K4 methylation and H3K9 
methylation (Jedrusik and Schulze, 2001, 2007).  In Xenopus, the oocyte- and embryo- 
specific H1 variant (named B4 or H1M) is replaced by somatic H1 variants during the 
transition from mid-blastula to neurulation (Andrews et al., 1991; Bouvet et al., 1994).  
This transition of H1 variants is the rate-limiting step for the loss of mesodermal 
competence, and ribozyme-mediated depletion of a somatic H1 variant leads to 
derepression of 5S rRNA expression and the regulatory genes required for loss of 
mesodermal competence during embryonic development (Bouvet et al., 1994; Kandolf, 
1994; Steinbach et al., 1997).  These studies suggest important roles of H1 variants in 
germline formation and embryogenesis of these organisms.  
Drosophila melanogaster differs from other metazoans in that there have been 
only two H1 variants identified, a somatic H1, dH1 (Nagel and Grossbach, 2000), and a 
recently identified embryonic H1, dBigH1 (Perez-Montero et al., 2013).  The reduced 
histone H1 complexity makes Drosophila an attractive system for investigating its in vivo 
functions.  RNA interference (RNAi)-mediated dH1 depletion by 80% causes larval 
lethality and abnormalities in major pericentric heterochromatin-associated histone marks 
including H3K9me2 and H4K20me2 (Lu et al., 2009).  The other fly H1 variant, dBigH1, 
mainly expressed during early embryogenesis and in germlines, shares the characteristic 





and the C-terminal domains with dH1, but it distinguishes itself with an unusual long N-
terminal domain enriched in negatively charged residues, suggesting a unique regulatory 
mechanism for dBigH1 (Perez-Montero et al., 2013).  Indeed, abrogation of dBigH1 
causes embryonic lethality at early development stages, likely due to a disruption in 
developmental programs by premature zygotic genome activation (Perez-Montero et al., 
2013).   
The first H1-null vertebrate cell line has been created by progressive deletion of 
all six H1 variants in DT40 chicken B lymphocytes.  Individual H1-deficient mutants 
exhibit enhanced expression of the remaining H1 genes and distinct changes in gene 
expression (Takami et al., 2000).  Complete H1 null DT40 cells display severe growth 
defects, decreased chromatin compaction, and increased chromosome aberration rates, as 
well as gene expression changes (Hashimoto et al., 2010).  In this study, however, 17 
core histone alleles were also removed by bulk deletion, making it difficult to assess 
whether the observed effects are solely attributable to the loss of histone H1.  
In mammals, there are 11 nonallelic H1 variants identified.  Gene targeting 
studies of H1 in mice have unveiled interesting features of H1.  Due to compensation of 
other H1 variants, mice with single or double knockout of somatic H1s (H1a, H1c, H1d, 
H1e, and H1
0
) are viable and develop normally (Fan et al., 2001; Lin et al., 2004; 
Sirotkin et al., 1995).  Nonetheless, further investigation reveals distinct phenotypes in 
certain single or double H1 knockouts.  For example, H1
0
 expression is found to be 
associated with production of dendritic cells, a type of antigen-presenting cells in the 
immune system, and H1
0
 deletion significantly impairs this process, suggesting a specific 
function of H1
0





phenomenon raised in certain single H1 knockout mice is the position effect variegation, 
defined as variations in the expression of a transgene caused by changes in the local 
chromatin structure in different cell types.  Loss of H1d and H1e, but not H1a, H1c, or 
H1
0
 attenuates age-dependent silencing of transgenes (Alami et al., 2003), indicating that 
H1 variants can differentially modulate higher order chromatin structures and gene 
expression.  Beside somatic H1 variants, knockout studies have also been performed in 
testis-specific H1 variants in mice.  Elimination of the most abundant H1 variant in 
spermatocyte, H1t, doesn’t have apparent effects on spermatogenesis (Drabent et al., 
2000; Fantz et al., 2001; Lin et al., 2000).  Yet, another testis-specific variant, H1T2, is 
found to be required for chromatin packaging and spermatid elongation during 
spermiogenesis (Martianov et al., 2005; Tanaka et al., 2005).  These studies establish 
both redundancy and specificity of the histone H1 family in mammals.  
An impressive progress on the study of histone H1 comes from compound 
deletion of three H1 variants, H1c, H1d, and H1e, in mice, which causes a 50% reduction 
in the total H1 level and embryonic lethality (Fan et al., 2003).  H1c/H1d/H1e triple 
knockout (H1 TKO) embryonic stem cells (ESCs) derived thereof show reduced 
chromatin compaction and nucleosome repeat length (Fan et al., 2005).  Interestingly, 
only a small number of genes are found to be affected in these cells, overrepresented by 
imprinted genes normally regulated by DNA methylation.  Marked reduction in the H1 
content in ESCs affects specific DNA methylation patterns at the regulatory regions of 
the affected genes which may be particularly sensitive to changes in H1 occupancy (Fan 
et al., 2005).  This level of H1 depletion also leads to a reduction in both H4K12 





to neutralize negative DNA charges in response to dramatic loss of H1, allowing for 
tighter chromatin compaction (Fan et al., 2005).  
Taken together, these studies on H1 disruption have shed significant light on the 
in vivo functions of histone H1 in various organisms.  H1 is not essential for protists, but 
play important developmental roles in metazoans.  Furthermore, both functional 
redundancy and specificity of H1 variants have been observed these studies.  
 
1.3 The Role of Histone H1 in Chromatin Compaction and Gene Regulation 
 
 Histone H1 binds to nucleosomes and linker DNA to protect additional ~20 bp of 
DNA (Meyer et al., 2011; Simpson, 1978; Syed et al., 2010), and the binding of H1 
dramatically affects nucleosomal spacing, with the total H1 level positively correlated 
with the nucleosome repeat length (NRL) (Woodcock et al., 2006).  Cells with a higher 
H1 to nucleosome ratio tend to have a longer NRL and more organized and compact 
chromatin fibers, and a reduction in H1 content leads to a reduced NRL and less compact 
chromatin (Fan et al., 2005; Hashimoto et al., 2010; Popova et al., 2013; Woodcock et al., 
2006).  Among the three domains, the globular and intrinsically disordered C-terminal 
domains are essential for chromatin binding and compaction (Allan et al., 1980; Allan et 
al., 1986; Hendzel et al., 2004; Luque et al., 2014).  Although the N-terminal domain 
appears to be nonessential for higher order chromatin compaction, its deletion or 
swapping between different H1 variants changes the binding affinity of the respective H1 
for chromatin (Allan et al., 1986; Hendzel et al., 2004; Oberg and Belikov, 2012; Vyas 





Different H1 variants exhibit significant sequence divergence from one another, 
especially in the C-terminal domain, suggesting distinct functions for these variants in 
chromatin compaction.  Indeed, FRAP studies have shown that H1 variants differ in 
chromatin binding affinity and residence time dependent on the length of the C-terminal 
tail, as well as on the density of basic residues and the number of S/TPXK 
phosphorylation sites (Th'ng et al., 2005).  Human H1a and H1c have the shortest C-
terminal domain and also residence time, whereas the variants with longer tails, namely 
H1b and H1e, show higher binding affinity for chromatin.  Recently, striking differences 
of H1 variants in the binding affinity for chromatin have also been demonstrated by in 
vitro and in vivo chromatin assembly studies (Oberg et al., 2012; Orrego et al., 2007).  
Given that H1 variants bind to DNA with distinct affinities and vary in their abilities in 
chromatin condensation (Clausell et al., 2009), the dramatically different compositions of 
H1 variants in various tissues could result in fine tuning chromatin condensation in both 
bulk chromatin and at specific regions in the genome. 
Because of its role in chromatin folding and its hyperphosphorylation as a 
hallmark of mitosis (Boggs et al., 2000; Hansen, 2002), histone H1 has been 
hypothesized to be a pivotal determinant of the mitotic chromosome structure.  Indeed, 
H1 has been shown to be essential for in vitro assembly of mitotic chromosomes in 
Xenopus egg extracts (Maresca et al., 2005).  In Drosophila, H1 is required for proper 
alignment of sister chromatids and the establishment of pericentric heterochromatin, 
likely mediated through recruitment of the heterochromatin-specific histone H3 lysine 9 
methyltransferase Su(var)3-9 (Lu et al., 2009; Lu et al., 2013).  The direct interaction of 





(Daujat et al., 2005; Hale et al., 2006; Nielsen et al., 2001; Studencka et al., 2012).  While 
H1x has been reported to be required for correct mitotic progression in HeLa cells, 
chicken lymphocytes with complete H1 knockout are not affected in mitotic 
chromosomal structure (Hashimoto et al., 2010; Takata et al., 2007).  Therefore, more 
evidence is needed to define the role of H1 in chromosomal integrity and mitotic 
chromosome structure.  
As an important component of eukaryotic chromatin, H1 is also engaged in 
epigenetic regulation including DNA methylation and histone modifications in multiple 
organisms.  In Ascobolus immersus and Arabidoposis thaliana, H1 abolishment leads to 
global DNA hypermethylation and stochastic alterations in DNA methylation 
respectively (Wendt et al., 2008; Wierzbicki and Jerzmanowski, 2005).  In mammals, 
compound loss of three H1 variants causes loci-specific DNA hypomethylation in mouse 
ESCs (Fan et al., 2005).  This study for the first time establishes a connection between 
H1 and DNA methylation in mammals.  More recently, H1 is shown to promote and 
maintain DNA methylation by recruiting DNA methyltransferases, DNMT1 and 
DNMT3B, to specific regions in the genome (Kashiwagi et al., 2011; Yang et al., 2013). 
Beside its interaction with DNMT’s, both in vitro and in vivo studies have 
identified physical interactions of H1 with enzymes responsible for specific histone 
modifications, including PRC2-EZH2 complex (Martin et al., 2006), which catalyzes 
H3K27 di- and tri- methylation (Cao et al., 2002; Margueron et al., 2008; Shen et al., 
2008), and SirT1, a histone deacetylase preferentially targeting to H3K9Ac and 
H4K16Ac (Vaquero et al., 2004).  Histone marks affected by H1 depletion include H3K4 





dimethylation and H4K20 dimethylation in Drosophila (Lu et al., 2009), and H4K12 
acetylation and H3K27 trimethylation in mouse ESCs (Fan et al., 2005).  These results 
reinforce the role of H1 in epigenetic regulation of genes.  
 A plethora of studies unravel H1 to be gene-specific regulators.  For example, H1 
forms a complex with CHD8 to suppress p53-mediated transcription and apoptosis during 
early embryogenesis (Nishiyama et al., 2009).  In addition, H1 is shown to modulate the 
expression of specific genes in ESCs, which is mediated at least partially through its 
effects on DNA methylation (Fan et al., 2005; Giambra et al., 2008; Maclean et al., 2011).  
In human promonocytes, H1 coordinates with HMGB1, a member of non-histone 
chromatin-associated proteins, to silence proinflammatory tumor necrosis factor alpha 
(TNF-α) and interleukin 1β (IL-1β) after the initiation of severe systemic inflammation 
(Cato et al., 2008; El Gazzar et al., 2009).  H1 has also been shown to compete with 
PARP-1 (poly(ADP-ribose) polymerase-1) in regulating gene expression in human breast 
cancer cells (Krishnakumar et al., 2008; Shan et al., 2014).  
Other lines of evidence demonstrate variant specificities of H1 in gene regulation.  
Msx1 specifically interacts with H1b at a key regulatory element of MyoD, a central 
regulator of skeletal muscle differentiation, to suppress myogenesis during embryonic 
development (Lee et al., 2004).  Overexpression of H1
0
 and H1c elicits different effects 
in gene expression in 3T3 cells and knockdown of individual H1 variants in human breast 
cancer cell line T47D also causes expression changes in specific genes (Brown et al., 
1997; Gunjan and Brown, 1999; Sancho et al., 2008).  Using a set of single H1 variant 
knockout mice, Alami et al. find that H1 variants can differentially affect transgene 





(Alami et al., 2003).  H1c specifically interacts with Cul4A E3 ubiquitin ligase and PAF1 
elongation complexes to activate gene transcription by inducing H4K31 ubiquitination, 
H3K4me3, and H3K79me2 (Kim et al., 2013).  Recently, we also demonstrated that 
overexpression of H1d, but not other H1 variants, potently represses the noncoding 
oncogene H19 in ovarian cancer cells (Medrzycki et al., 2014).  Modulation of the 
expression levels of specific H1 variants inhibits cell growth, which is likely due to, at 
least partially, the effects of H1 on gene expression.  The difference of H1 variants in 
gene regulation is probably owing to their different affinities for chromatin and capacities 
for DNA compaction, as well as the divergent C-terminal domain (Clausell et al., 2009; 
Th'ng et al., 2005). 
Recent genome-wide profiling studies on epitope-tagged H1 variants take a 
different approach to elucidate H1 functions, which show that H1 is generally depleted at 
GC-rich and gene-rich regions and active promoters, as well as regulatory elements 
controlling transcription (Cao et al., 2013; Izzo et al., 2013; Millan-Arino et al., 2014).  In 
particular, H1 occupancy at transcription start sites appears to be positively correlated 
with the repressive histone mark H3K9me3 and in negative correlation with the active 
histone mark H3K4me3.  Taken together, these studies indicate that H1 variants are 
important in regulating specific gene expression. 
In addition to the aforementioned functions, H1 is also implicated in genome 
surveillance and DNA repair.  An intriguing example is the direct involvement of H1c in 
double-strand break induced apoptosis (Konishi et al., 2003).  When initiated by X-ray- 
or etoposide- induced DNA double-strand breaks, H1c (but not other H1 variants) 





stimulate cell apoptosis (Konishi et al., 2003).  H1 also has been reported to suppress 
p53-mediated transcription and apoptosis through association with other cofactors (Kim 
et al., 2008; Nishiyama et al., 2009).  Moreover, H1 can serve as a stimulating factor for 
non-homologous end-joining and homologous recombination mediated DNA repair 
(Hashimoto et al., 2007; Rosidi et al., 2008), and H1 depletion increases DNA damage 
response in yeast and mouse ESCs (Downs et al., 2003; Murga et al., 2007).  These 




Previous studies have shown that compound depletion of H1c/H1d/H1e leads to 
specific changes in gene regulation (Fan et al., 2005) and impaired ESCs differentiation 
(Zhang et al., 2012).  However, there is still 50% H1 remaining in these cells.  Therefore, 
one goal of this study is to determine if H1 is essential for ESC self-renewal and 
differentiation by depleting the remaining H1 variants in ESCs and to investigate the 
underlying regulatory mechanisms.  On the other hand, recurrent mutations in multiple 
H1 variants have been identified in follicular lymphoma (Li et al., 2014; Lohr et al., 2012; 
Morin et al., 2011; Okosun et al., 2014).  Therefore, the other goal of this study is to 
elucidate how H1 mutations will affect their in vivo functions and contribute to 
tumorigenesis.  Completion of this study is expected to provide new insights into the 
functions of histone H1 in chromatin compaction and gene regulation during 
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Linker histone H1, a key structural protein involved in the formation of higher 
order chromatin structures, is emerging as an important epigenetic mark and regulator for 
gene expression and cell differentiation.  Here, we establish embryonic stem cells (ESCs) 
with an ultra-low histone H1 level by sequential depletion of H1 variants.  ESCs with 
severe H1 depletion display normal ESC morphology and self-renewal, as well as 
specific changes in epigenetic marks.  The total H1 level gradually increases during 
neural differentiation, which corresponds to a global chromatin condensation in 
differentiating cells.  In vitro neural differentiation of ESCs with sequential H1 depletion 
revealed a dosage effect of H1 on neural differentiation of embryonic stem cells, as 
indicated by neurite outgrowth, induction of neural lineage-specific genes, and repression 
of pluripotency genes such as Oct4 and Nanog.  Moreover, severe H1 depletion causes a 
reduction in cell proliferation and cellular senescence in neural lineages.  Significantly, 
Oct4 knockdown effectively rescues the defects in neural differentiation and partially 
reverses the reduction in cell proliferation and cellular senescence.  Our results suggest 
that, despite a global impact of histone H1 on chromatin condensation, the regulation of 








In eukaryotic nuclei, ~147 base pairs of DNA is wrapped around an octamer of 
core histones to form a fundamental unit called a nucleosome (Davey et al., 2002; Luger 
et al., 1997).  The linker histone H1 seals the nucleosomes at the entry and exit sites of 
DNA to facilitate and stabilize the folding of the 30 nm chromatin fiber (Ramakrishnan, 
1997; Thoma et al., 1979; Wolffe, 1997).  Histone H1 has a generic tri-partite structure 
consisting of a short, flexible N-terminal tail, a highly conserved globular domain with a 
winged-helix motif, and a long extended lysine-rich C-terminal tail (Allan et al., 1980; 
Chapman et al., 1976; Ramakrishnan et al., 1993).   
A prominent characteristic of the histone H1 family is its heterogeneity.  In 
mammals, 11 closely related non-allelic H1 variants have been identified, including 7 
somatic H1 isoforms (H1
0
, H1a-e, and H1x), 3 testicular isoforms (H1t, H1T2, and 
HILS1), and one oocyte-specific isoform (H1oo) (Happel and Doenecke, 2009).  Among 
somatic H1 variants, H1a-e are replication-dependent and mainly expressed in the S 
phase of the cell cycle, whereas the replacement variant, H1
0
, is replication-independent 
and enriched in terminally differentiated cells that have stopped dividing (Khochbin, 
2001; Zlatanova and Doenecke, 1994).  The most divergent variant, H1x, shares only 30% 
similarity in amino acid sequence with other H1 variants and is the least characterized 
member (Happel et al., 2005; Yamamoto and Horikoshi, 1996).  Ample evidence 
suggests that histone H1 plays specific roles in gene regulation during embryogenesis and 
in various cell types (Alami et al., 2003; El Gazzar et al., 2009; Fan et al., 2005; Giambra 





variants in gene expression are likely owing to their different binding affinities for 
chromatin and capacities for DNA compaction, as well as the divergent C-terminal 
domain (Clausell et al., 2009; Th'ng et al., 2005).  
ESCs possess the capacity to self-renew indefinitely and differentiate into almost 
all cell lineages, offering great promise in regenerative medicine and cellular therapies.  
ESCs maintain an open and relaxed chromatin structure, with hyperdynamic binding of 
structural chromatin proteins and hyperactive global transcriptional activity as hallmarks 
(Efroni et al., 2008; Meshorer et al., 2006).  During differentiation, ESCs undergo 
dramatic molecular changes, including silencing of pluripotency genes such as Oct4 (also 
known as Pou5f1) and Nanog, and activation of lineage-specific genes (Loebel et al., 
2003).  In addition, the genome of differentiating ESCs undergoes global chromatin 
remodeling and epigenetic reprogramming (Jaenisch and Bird, 2003; Rasmussen, 2003). 
Mouse ESCs have an H1/nucleosome ratio of 0.46 (Fan et al., 2005), 
approximately 1 H1 per 2 nucleosomes, versus that up to 0.75~0.8 in adult cells (Fan et 
al., 2003; Woodcock et al., 2006), also suggesting an open chromatin state in pluripotent 
stem cells versus a compact chromatin state in differentiated cells.  ESCs with a 
compound deletion of 3 somatic H1 variants (H1c, H1d, and H1e) (H1 TKO) have on 
average only 1 H1 per 4 nucleosomes (H1/nucleosome ratio at 0.25) (Fan et al., 2003; 
Fan et al., 2005).  H1 TKO ESCs display decondensed structure in bulk chromatin but 
specific changes in gene expression (Fan et al., 2003; Fan et al., 2005).  Subsequent 
investigations reveal that H1 TKO ESCs are impaired in ESC differentiation and that 
pluripotency genes such as Oct4 and Nanog are not efficiently repressed during 





total H1 level is critical for ESC differentiation.  However, it remains elusive if H1 is 
essential for ESC self-renewal and how high order chromatin packaging modulates ESC 
differentiation. 
In the current study, we established ESCs with an ultra-low H1 level by sequential 
depletion of H1 variants, which had an H1/nucleosome ratio of ~0.11, approximately one 
fourth of that in wildtype (WT) ESCs.  By studying ESCs with different levels of H1 
depletion, we uncovered a dosage effect of H1 on ESC differentiation, as indicated by 
neurite outgrowth, induction of neural lineage-specific genes, and repression of 
pluripotency genes such as Oct4 and Nanog.  Surprisingly, ESCs with severe H1 
depletion were not affected in ESC morphology and self-renewal.  However, severe H1 
depletion caused a reduction in cell proliferation and cellular senescence in neural 
lineages.  Finally we found that Oct4 knockdown effectively rescued the defects in neural 








2.3 Materials and Methods 
 
2.3.1 Generation of H1c/H1d/H1e/H1
0




































 mice, cultured in vitro to establish ESC lines, and 
genotyped to screen for H1c/H1d/H1e/H1
0
 quadruple knockout (H1 QKO) ESCs as 
previously described (Fan et al., 2003; Fan et al., 2005).  Animal breeding and 
experimental procedures were approved by Georgia Tech Institutional Animal Care and 
Use Committee. 
 
2.3.2 Cell culture and growth curve assay 
ESCs were propagated on mitotically inactivated mouse embryonic fibroblast 
feeder layers in tissue culture dishes (Corning) coated with 0.1% gelatin (Sigma-Aldrich).  
Prior to experiments such as HPLC analysis, ESCs were grown on feeder-free culture 
dishes for feeder removal.  ESC culture media consisted of Dulbecco's modified Eagle's 
medium (DMEM) (Life Technologies) supplemented with 15% fetal bovine serum (FBS) 
(Gemini), 100 U/ml penicillin (Life Technologies), 100 μg/ml streptomycin (Life 
Technologies), 1X MEM nonessential amino acids (Life Technologies), 0.1 mM β-
mercaptoethanol (Life Technologies), and 103 U/ml of leukemia inhibitory factor (LIF; 
ESGRO, Chemicon).  Cultures were re-fed with fresh media every other day, and 





expression of shRNAs, ESC culture media were supplemented with 1 μg/ml doxycycline 
(Dox) (Sigma-Aldrich).  For growth curve assay, ESCs were seeded without feeder cells 
on 12-well plates at a density of 1 x 10
4
 cells/well.  The cells were trypsinized with 0.25% 
trypsin-EDTA solution and counted on a hemocytometer in triplicates every 2 days for up 
to 6 days.   
 
2.3.3 Construction of the inducible vector for H1a and H1b knockdown and 
generation of ESCs with an ultra-low H1 level (QKO/abi ESCs) 
The Tet-On inducible shRNA expression vector pTRIPZ and the TransLenti viral 
packaging system were purchased from Open Biosystems.  One copy of H1a shRNA and 
two copies of H1b shRNA embedded in the miR-30 backbone were inserted into the 
pTRIPZ vector.  The shRNA-miR-30 sequences are as follows: H1a shRNA-miR-30, 5’-
aagaaggtatattgctgttgacagtgagcgACAGGCAGTTTCTTCTTCCAAAtagtgaagccacagatgta-
TTTGGAAGAAGAAACTGCCTGCtgcctactgcctcggacttcaaggg-3’; H1b shRNA-miR-30, 
5’-aagaaggtatattgctgttgacagtgagcgACTCTGGTTCCTTCAAGCTTAAtagtgaagccacagat-
gtaTTAAGCTTGAAGGAACCAGAGGtgcctactgcctcggacttcaaggg-3’.  Capital letters 
indicate the sense and antisense sequences.  Viral particles containing the re-constituted 
vector were produced according to the manufacturer’s manual, and transduced into H1 
QKO ESCs for growth into colonies.  The resulting ESC clones were propagated and 
induced with 1 μg/ml Dox for HPLC analysis to confirm the depletion of H1a and H1b.  
Positive clones were designated as QKO/abi ESC lines.  
 





Chromatin and histones were prepared from ESCs and embryoid bodies (EBs) 
according to protocols described previously (Cao et al., 2013; Fan and Skoultchi, 2004; 
Medrzycki et al., 2012).  Approximately 50 μg of total histones were injected into a C18 
reverse phase column (Vydac) on an Äktapurifier UPC 900 system (GE Healthcare).  
Linker histones and core histones were fractionated with an increasing acetonitrile 
gradient as described previously (Medrzycki et al., 2012).  The effluent was monitored at 
214 nm wavelength, and the peak areas were analyzed with AKTA UNICORN 5.11 
software (GE Healthcare).  The areas of A214 peaks of H1 variants and H2B were 
normalized by the number of peptide bonds of respective histone proteins, and the 
normalized values were used for calculation of H1 to nucleosome (H1/nuc) ratio (Fan and 
Skoultchi, 2004; Medrzycki et al., 2012).  
 
2.3.5 In vitro neural differentiation of ESCs 
Neural differentiation of ESCs was performed following a protocol established 
previously with some modifications (Zhang et al., 2012a).  Briefly, ESCs were 
trypsinized with 0.25% trypsin-EDTA solution, depleted of feeder cells, and resuspended 
in differentiation media at 5 x 10
4
 cells/ml.  The differentiation media had the same 
composition as ESC culture media but without LIF.  EBs were formed in hanging drops 
of 20 μl volume (containing 1000 cells) and incubated for 5 days.  Subsequently, EBs 
were collected into ultra-low attachment dishes (Corning) and treated with 1 μM all-trans 
retinoic acid (Sigma-Aldrich) for additional 3 days.  For neural differentiation, day 8 EBs 
were seeded on tissue culture dishes coated with 5 μg/ml poly-L-ornithine (Sigma-





medium (StemCell Technologies) supplemented with 100 ng/ml bFGF (GenScript) for up 
to 15 days.  Day 8+5, 8+10, and 8+15 EBs were taken for subsequent analyses as 
indicated.  1 μg/ml Dox was supplemented during neural differentiation as needed.  For 
QKO/abi/Oct4i+Dox EBs, Dox was added on day 5.  Statistical analysis of neurite 
numbers was performed using GraphPad Prism 4 software (GraphPad Software).  
 
2.3.6 Antibodies 
 The following antibodies were used for Western blotting and 
immunocytochemistry: anti-Oct4 (Santa Cruz, sc-8628), anti-GAPDH (Millipore, 
MAB374), anti-β-actin (Sigma-Aldrich, A5316), anti-FLAG (Sigma-Aldrich, F1804), 
anti-H3K4me3 (Millipore, 07-473), anti-H3K9me2 (Abcam, ab1220), anti-H3K9me3 
(Abcam, ab8898), anti-H3K27me3 (Millipore, 07-449), anti-H3 (Abcam, ab1791), anti-
GFAP (Dako, Z0334), anti-TUBB3 (Millipore, MAB1637); anti-Nestin (Millipore, 
MAB353), anti-BrdU (Abcam, ab1893).  
 
2.3.7 Immunocytochemistry 
Immunostaining of day 8+5 and 8+10 EBs was performed as previously described 
(Zhang et al., 2012a).  Briefly, EBs grown on glass coverslips were fixed with 4% 
paraformaldehyde for 20 min and permeabilized with 0.2% Triton X-100/PBS for 30 min 
at room temperature, followed by blocking with 10% FBS/PBS for 1 h at room 
temperature.  EBs were then immunostained with primary and secondary antibodies.  The 
following secondary antibodies were used: Cy3-conjugated donkey anti-rabbit IgG 





donkey anti-mouse IgG (Life Technologies, A-21202).  Nuclei were counter-stained with 
Hoechst 33342 (Molecular Probes).  Images were collected on an Olympus Fluorescence 
Microscope with a Q-Color 3 CCD camera (Olympus).  
 
2.3.8 RNA extraction and quantitative RT-PCR 
RNA extraction and quantitative RT-PCR (qRT-PCR) were performed as 
previously described (Medrzycki et al., 2012; Zhang et al., 2012a).  Briefly, total RNA 
from ESCs and EBs were extracted using the Allprep DNA/RNA Mini Kit (Qiagen) 
following the manufacturer’s instruction.  RNA samples were reverse transcribed with 
the SuperScript III First-Strand Synthesis System (Life Technologies).  Real-time 
quantitative PCR was performed using iQ SYBR Green Supermix on the MyIQ Single 
Color Real-Time PCR Detection System (Bio-Rad).  The following primers were used: 
Oct4: forward 5’-GCTCACCCTGGGCGTTCTC-3’, reverse 5’-
GGCCGCAGCTTACACATGTTC-3’; Tyrosine hydroxylase: forward 5’-
GATTGCAGAGATTGCCTTCC-3’, reverse 5-GGGTAGCATAGAGGCCCTTC-3’; 
Nestin: forward 5’-GCCTATAGTTCAACGC CCCC-3’, reverse 5’-AGAC 
AGGCAGGGCTAGCAAG-3’; GFAP: forward 5’-GCCACCAGTAACATGCAAGA-3’, 
reverse 5’-GGCGATAGTCGTTAGCTTCG-3’; GAPDH: forward 5’-
TTCACCACCATGGAGAAGGC-3’, reverse 5’-GGCATGGACT GTGGTCATGA-3’; 
TUBB3: forward 5’-CATGGACAGTGTTCGGTCTG-3’, reverse 5’-
CGCACGACATCTAGGACTGA-3’. 
 
2.3.9 Generation of H1d rescue (QKO/abi/H1
res





An expression vector containing H1d CDS and 5 kb mouse H1d upstream and 
downstream regulatory regions and the blasticidin resistant gene were established 
previously (Zhang et al., 2012a).  20 μg of plasmid DNA was transfected into 2 x 10
7
 
QKO/abi ESCs by electroporation and a total of 24 clones resistant to blasticidin (Life 
Technologies) were picked and screened by Western blotting using an anti-FLAG 
antibody.  Two cell lines with the highest levels of H1d were selected as QKO/abi/H1
res
 
cell lines for further analysis. 
 
2.3.10 Generation of ESCs with inducible Oct4 knockdown 
Similar to construction of the vector for inducible H1a and H1b knockdown, Oct4 
shRNA-miR-30 cassettes were inserted between XhoI and EcoRI sites in the pTRIPZ 
vector.  Oct4 shRNA-miR30’s are as follows: 5’-ccagccttaagaacatgtgtaatagtgaagcc-
acagatgtattacacatgttcttaaggctga-3’, 5’-acccggaagagaaagcgaactatagtgaagccacagatgtatagttc-
gctttctcttccgggc-3’.  The puromycin resistant gene in the pTRIPZ vector was replaced 
with the blasticidin resistant gene for clone selection.  The re-constituted viral vector was 
packaged into virus and transduced into QKO/abi ESCs.  Blasticidin resistant clones were 
picked, induced with 1 μg/ml Dox, and screened for Oct4 knockdown by Western 
blotting using an anti-Oct4 antibody.  Two clones with highest knockdown efficiency 
were selected as QKO/abi/Oct4i ESC lines for further analysis.  
 
2.3.11 Measurement of EB size 
Day 5 EBs were collected from hanging drops and phase contrast images were 





AxioVision software as area and EB diameters were then calculated.  Over 150 EBs for 
each line from 3 independent experiments were pooled and statistically analyzed with 
GraphPad Prism 4 software. 
 
2.3.12 BrdU incorporation assay of EBs 
Day 8+5 EBs grown on glass coverslips were pulsed with 10 μg/ml 5-bromo-2'-
deoxyuridine (BrdU; BD Pharmingen) for 2 h, then washed 3 times with PBS, and fixed 
with 4% paraformaldehyde for 20 min, followed by permeabilization with 0.2% Triton 
X-100/PBS for 20 min at room temperature.  Subsequently, EBs were treated with 2N 
hydrochloric acid (HCl) for 30 min, and neutralized with 100 mM Tris-HCl buffer, pH8.0, 
for 20 min at room temperature.  For immunostaining of BrdU, EBs were hybridized with 
an anti-BrdU antibody, and Cy3-conjugated Donkey anti-Sheep IgG (Jackson 
ImmunoResearch Laboratories, 713-165-147).  Images were collected at 60X on an 
Olympus fluorescence microscope. 
 
2.3.13 Senescence associated β-Galactosidase staining of EBs 
ESCs and Day 8+5 EBs cultured on 6-well plates were stained for β-
Galactosidase activity using the Senescence β-Galactosidase Staining Kit (Cell Signaling, 
#9860) following the manufacturer’s manual.  Images were taken with a Carl Zeiss 
AxioVision system.  
 






 1 μg genomic DNA extracted from ESCs was completely digested with the 
methylation-insensitive restriction enzyme, MspI, and methylation-sensitive restriction 
enzymes, HpaII and MaeII.  The digested DNA samples were separated by gel 
electrophoresis and stained with ethidium bromide (AMRESCO).   
 
2.3.15 Cell cycle analysis of ESCs 
 ESCs in exponential expansion phase were trypsinized and washed with PBS, 
followed by fixation with 75% ethanol.  For cell cycle analysis, fixed cells were 
resuspended in PBS and stained with 1 μg/ml Hoechst 33342 for 20 min at room 
temperature.  Data were collected on a BD LSRII Flow Cytometer (BD Biosciences) and 



















2.4.1 Generation of H1c/H1d/H1e/H1
0
 quadruple knockout ESCs 
To begin to make ultra-low H1 ESCs, we first set out to generate 
H1c/H1d/H1e/H1
0

































 mice, were embryonic lethal and 
died by embryonic day 8.5 (E8.5), earlier than those with triple-H1 deficiency (Fan et al., 
2003).  From the outgrowth of quadruple-H1 null blastocysts, we derived 
H1c/H1d/H1e/H1
0









 ESCs displayed normal ESC morphology and comparable 
expression of pluripotency gene Oct4 as WT ESCs, as well as growth rate and cell cycle 
distribution (Figure 2.2).  Total histones were extracted from wildtype (WT) and H1 
QKO ESCs and subjected to reverse phase (RP)-HPLC analysis.  The HPLC profile of 
H1 QKO ESCs showed the absence of H1c, H1d, H1e, and H1
0
 variants, demonstrating 
the deletion of these four H1 variants (Figure 2.3A).  Calculation of H1/nucleosome 
(H1/nuc) ratio from H1 and H2B peaks showed that H1 QKO ESCs had an H1/nuc ratio 
of ~0.24 (Figure 2.3B), slightly lower than that of 0.25 in H1 TKO ESCs (Fan et al., 
2005), which is consistent with the low/minimum levels of H1
0
 (~2% of total H1) in WT 
ESCs.  In H1 QKO ESCs, H1a and H1b accounted for 30% and 70% of the total H1 level 





exists in a very low amount in ESCs and does not noticeably compensate for loss of other 






















Figure 2.1 A schematic view of the process for generation of H1c/H1d/H1e/H1
0
 




























Figure 2.2 Characterization of H1 QKO ESCs. 
H1 QKO ESCs exhibit similar colony morphology (A), Oct4 expression (B), growth rate 




























A) HPLC profiles of wildtype (WT) and H1 QKO ESCs. X axis: elution time; Y axis: 
absorbency at A214; mAU, milli-absorbency units. 
B) Quantification of H1 levels as H1 to nucleosome ratio according to HPLC profiles in 
(A). Values are shown in means ± S.D., n = 3. ns: not significant; *: p<0.05; ***: 
p<0.001. 





2.4.2 Generation of ESCs with an ultra-low H1 level 
To deplete the remaining H1a and H1b variants in H1 QKO ESCs and to avoid 
the potential deleterious effects on ESC viability by complete H1 elimination, we 
employed a Tet-On inducible RNAi vector, pTRIPZ.  To simultaneously deplete both 
variants, one copy and two copies of H1a shRNA and H1b shRNA respectively were 
inserted into the shRNA-miR cassette of pTRIPZ vector (Figure 2.4) (Sun et al., 2006).  
Two copies of H1b shRNA were inserted for knockdown of H1b expression because of a 
higher percentage of H1b than H1a, 70% vs. 30%, in the remaining H1s.  H1 QKO ESCs 
transduced with the reconstituted lentiviral vector were established as QKO/abi ESCs.  
The HPLC profile of histone extracts from QKO/abi ESCs showed a dramatic reduction 
in H1a and H1b upon induction with doxycycline (Dox) (Figure 2.5A).  In the absence of 
Dox, QKO/abi (QKO/abi-Dox) ESCs had a similar H1 level as H1 QKO ESCs (Figures 
2.3B and 2.5B).  Upon induction with Dox, the total H1/nuc ratio in QKO/abi 
(QKO/abi+Dox) ESCs was reduced to ~0.11 4 days post induction.  QKO/abi+Dox ESCs 




































The reverse tetracycline transactivator 3 (rtTA3), which is ubiquitously expressed, can 
bind to the tetracycline responsive element (TRE) and activate the expression of 
TurboRFP (tRFP) and shRNA-miR hairpins in the presence of Dox. The shRNA-miR-30 
cassette consists of one copy of H1a shRNA and two copies of H1b shRNA connected 
by artificial sequences and restriction sites. 5’ LTR, 5’ long terminal repeat; Ψ, retroviral 
Psi packaging element; cPPT, central polypurine tract; Zeo
r
, Zeocin resistant gene; UBC, 
ubiquitin C promoter; IRES, internal ribosome entry site; Puro
r
, puromycin resistant 
gene; WRE, woodchuck hepatitis virus posttranscriptional regulatory element; SinLTR, 
self-inactivating long terminal repeat. 
Figure 2.4 A schematic view of the lentiviral vector pTRIPZ encompassing H1a and 














A) HPLC profiles of uninduced and induced QKO/abi ESCs. X axis: elution time; Y 
axis: absorbency at A214; mAU, milli-absorbency units. 
B) Quantification of H1 levels as H1 to nucleosome ratio according to HPLC profiles in 
(A). Values are shown in means ± S.D., n = 3. **: p<0.01; ***: p<0.001. 





2.4.3 Phenotypic analysis of ESCs with an ultra-low H1 level 
To investigate the effects of severe H1 depletion in ESCs, we induced the 
expression of H1a shRNA and H1b shRNA using Dox.  Upon induction, QKO/abi ESCs 
did not show noticeable changes in colony morphology, the expression of the 
pluripotency gene Oct4, growth rate, and cell cycle profile, as compared with WT ESCs 
(Figure 2.6).  These results indicate that severe depletion of the H1 level to as few as 1 

















Figure 2.6 Characterization of QKO/abi ESCs. 
QKO/abi+/-Dox ESCs exhibit similar colony morphology (A), Oct4 expression (B), 





2.4.4 Analysis of DNA methylation and histone modifications in bulk chromatin of 
ultra-low H1 ESCs 
Previous studies show that triple-H1 deletion does not change the overall DNA 
methylation but causes reduction in certain histone marks in ESCs (Fan et al., 2005).  To 
investigate how further H1 depletion affects epigenetic marks in ESCs, we first 
performed Western blotting to compare several key histone marks in WT ESCs and ESCs 
with sequential H1 depletion.  While the overall levels of the active histone mark, 
H3K4me3, and the repressive histone marks, H3K9me2 and H3K9me3, remained 
unchanged, the level of H3K27me3 was progressively reduced after sequential H1 
depletion (Figure 2.7).  These results further support a role of H1 in regulating specific 
histone modifications in bulk chromatin.  
To determine if a severe reduction of the H1 level causes DNA methylation 
changes in bulk chromatin, genomic DNA from WT and H1-depleted ESCs was digested 
with DNA methylation-sensitive restriction enzymes, HpaII or MaeII, which recognize 
CCGG and ACGT respectively.  Both HpaII and MaeII are blocked by CpG methylation 
which occurs on the 5’ of cytosine at CpG configuration.  As a control, genomic DNA 
was digested with DNA methylation-insensitive restriction enzyme MspI, which 
recognizes the same recognition sequence as HpaII, CCGG.  While genomic DNA was 
nearly fully digested by MspI, majority of DNA was resistant to the digestion by HpaII or 
MaeII, indicating that genomic DNA of these ultra-low H1 ESCs remain heavily 
methylated (Figure 2.8).  These results suggest that severe H1 depletion does not 





























Figure 2.7 Overall levels of selective histone marks in ESCs with sequential H1 
depletion. 
Western blotting of the active histone mark, H3K4me3, and the repressive histone marks, 
H3K9me2, H3K9me3, and H3K27me3, in wildtype (WT), H1 TKO (TKO), H1 QKO 




























Genomic DNA extracted from ESC lines was digested with the methylation-insensitive 
restriction enzyme, MspI, and methylation-sensitive restriction enzymes, HpaII and 
MaeII, followed by gel electrophoresis. W, wildtype; T, H1 TKO; Q1, QKO/abi-Dox 
clone 1; Q2, QKO/abi-Dox clone 2; Q1*, QKO/abi+Dox clone 1; Q2*, QKO/abi+Dox 
clone 2. 





2.4.5 A dosage effect of histone H1 on neural differentiation of ESCs 
As we have previously shown, triple-H1 null ESCs are impaired, but not 
completely blocked, in neural differentiation (Zhang et al., 2012a).  Having established 
ultra-low H1 ESCs, we set out to examine how further H1 depletion affects ESC 
differentiation.  We employed an in vitro neural differentiation scheme (Figure 2.9) 
which we optimized based on a previous protocol (Kim et al., 2009; Zhang et al., 2012a).  
The neural differentiation regimen provides an ideal approach to study the regulatory 
mechanisms of ESC differentiation.  Embryoid bodies (EBs) grown in hanging drops for 
5 days were treated with all-trans retinoic acid (RA) for additional 3 days, followed by 
neural differentiation on poly-L-ornithine (PLO)- and laminin- coated culture dishes for 
up to 15 days.  Of note, at day 5, QKO/abi EBs with Dox induction formed in hanging 
drops showed significantly smaller EB size (Figure 2.10), which was in sharp contrast to 







































Day 5 EBs prepared from hanging drops were measured in diameters (μm). Data were 
collected from 3 independent experiments and are presented in Box-and-whisker plots, N 
≥ 150. ns: not significant; ***: p<0.001. 





During the development of the central nervous system, immature neurons migrate 
long distances to their destinations, form axons and dendrites, and are eventually 
orchestrated into neural networks.  Upon differentiation following the neural 
differentiation protocol described above, by day 8+5, WT EBs sprouted numerous thick 
and extended neurites, and were surrounded by a radial monolayer of migrated neural 
cells (Figure 2.11A).  Similar cell migration patterns were observed in H1 TKO and 
QKO/abi-Dox EBs, whereas QKO/abi+Dox EBs exhibited impaired migration of neural 
cells.  Quantitative measurements showed that on average 79% of WT EBs formed 
neurite outgrowth with an average of 38 neurites per EB, versus 35% of H1 TKO EBs 
with an average of 14 neurites per EB (Figure 2.11B).  Severe H1 depletion caused an 
enhanced hindrance in neurite outgrowth: 23% of QKO/abi-Dox EBs formed 9 neurites 
on average, with the numbers dropping to 19% and 3 in QKO/abi+Dox EBs, respectively.  
The dosage effect of H1 depletion on neurite outgrowth was confirmed by 
immunostaining of neuron-specific β-tubulin isotype III (TUBB3), which is rich in 
neurites.  By day 8+5, WT EBs exhibited abundant thick bundles of microtubules with 
bright TUBB3 staining (Figure 2.12), whereas both the quantity and thickness of neurites 
were compromised in H1 TKO EBs, with a more drastic decrease in QKO/abi (±Dox) 
EBs.  Collectively, our results suggest a dosage effect of histone H1 variants on ESC 
differentiation towards neuronal lineages, with progressively more severe defects with 































A) Phase contrast images of day 8+5 EBs. Scale bar, 200 μm. 
B) Left panel: percentage of neurite-forming EBs. Numbers were averaged from at least 
4 experiments. Over 100 EBs were counted per experiment. Right panel: numbers of 
neurites per neurite-forming EB. Neurite number was counted from EBs that produced 
neurites. Dox was added to media when EB cultures were induced. All data are presented 
as means ± S.D. *: p<0.05; ***: p<0.001. 
 
Figure 2.11 Sequential H1 depletion leads to a progressive decrease of neurite outgrowth 



























TUBB3 was stained in green color and nuclei counterstained with Hoechst in blue. Scale 
bar: 200 μm. 





Next we examined ESC differentiation towards other neural lineages.  The early 
developmental stages of the nervous system are marked by neural stem cells (NSCs), 
which can differentiate into diverse neural lineages.  To examine the production of NSCs, 
we immunostained the NSC marker Nestin in day 8+5 EB cultures.  The results showed 
that WT EBs were enriched in cells with abundant Nestin filaments (Figure 2.13 upper 
panels).  In contrast, H1 depletion progressively repressed Nestin expression, reaching a 
trace level in EBs with an ultra-low H1 level (QKO/abi+Dox EBs).  In addition to 
neurogenesis, we further assessed gliogenesis by immunostaining of the astrocyte marker, 
glial fibrillary acidic protein (GFAP), in day 8+10 EB cultures, given that the gliogenic 
process occurs after neurogenesis during in vivo brain development (Qian et al., 2000).  
Remarkably, in sharp contrast to WT EB cultures, the number of glial cells was 
drastically decreased in H1 TKO EB cultures and no GFAP-positive cells were detected 
in QKO/abi (±Dox) EB cultures (Figure 2.13 lower panels).  It is noteworthy that these 
defects in neural differentiation of ultra-low H1 ESCs were not observed in H1 QKO 
ESCs transduced with scramble shRNA (QKO/sci ESCs) and induced with Dox (Figures 
2.14, 2.15, and 2.16), further suggesting that the blockage in neural differentiation of 


















Day 8+5 and 8+10 EBs were immunostained against the neural stem cell marker Nestin 
(upper panels) and the glial cell marker GFAP (lower panels), respectively. Nuclei were 
counterstained with Hoechst in blue color. Scale bar: 20 μm. 
Figure 2.13 Sequential H1 depletion causes a progressive decrease in the expression of 




























Left panel: Percentage of neurite-forming EBs. Numbers were averaged from at least 4 
experiments. Over 100 EBs were counted per experiment. 
Right panel: Numbers of neurites per neurite-forming EB. Neurite number was counted 
from EBs that produced neurites. QKO/sci, EBs formed from H1 QKO ESCs transduced 
with scramble shRNA. ns: Not significant. 




























TUBB3 was stained in green color and nuclei were counterstained with Hoechst in blue. 
Scale bar: 200 μm. 
Day 8+5 and 8+10 EBs were immunostained against the neural stem cell marker Nestin 
(upper panels) and the glial cell marker GFAP (lower panels), respectively. Nuclei were 
counterstained with Hoechst in blue color. Scale bar: 20 μm. 
Figure 2.15 Scramble shRNA and Dox have no effect on TUBB3 expression. 
Figure 2.16 Scramble shRNA and Dox have no effect on the expression of Nestin and 





Next, we examined the expression patterns of different neural markers throughout 
the course of neural differentiation by quantitative reverse-transcription PCR (qRT-PCR) 
to compare the temporal expression profiles of these markers in WT and ultra-low H1 
cells.  Nestin and GFAP expression was efficiently and progressively induced in WT EB 
cultures (Figure 2.17) and significant up-regulation of GFAP occurred starting from day 
8+10, consistent with the notion that neurogenesis is followed by gliogenesis during the 
development of the central nervous system.  The expression of TUBB3 and tyrosine 
hydroxylase (TH) reached peak levels at day 8+5 and decreased after an extended culture.  
While the expression of these neural markers was compromised in H1 TKO EB cultures 
as we observed previously (Zhang et al., 2012a), their expression was largely blocked in 
QKO/abi (±Dox) EB cultures throughout the culture course.  Collectively, our results 
indicate that a sufficient amount of histone H1 is required for the induction of neural 






































qRT-PCR analysis was performed to examine the expression of the neural stem cell 
marker Nestin, two neuronal markers TUBB3 and tyrosine hydroxylase (TH), and the 
glial marker GFAP in ESCs and differentiating EBs. Data were normalized over the 
expression of GAPDH and are presented as means ± S.D. 
 






2.4.6 H1 depletion causes dysregulation of pluripotency-associated genes during 
neural differentiation 
ESCs express pluripotency-associated genes like Oct4 and Nanog as hallmarks.  
These transcription factors play fundamental roles in maintaining ESC pluripotency and 
their downregulation is necessary for differentiation to occur (Liang et al., 2008; Loh et 
al., 2006; Mitsui et al., 2003; Niwa et al., 2000).  We have previously reported that Oct4 
is not efficiently silenced in H1 TKO cells during embryogenesis and EB differentiation 
(Zhang et al., 2012a).  We performed qRT-PCR analysis to determine if severe H1 
depletion further compromised the repression of Oct4 and Nanog expression during 
neural differentiation.  While the expression of Oct4 and Nanog was efficiently 
downregulated in WT EBs during neural differentiation, they remained at high levels in 
EBs with an ultra-low H1 level (QKO/abi+Dox EBs), even more drastic dysregulated 
than that in H1 TKO EBs.  These results demonstrate that severe depletion of H1 does 
not affect the expression of Oct4 and Nanog in ESCs but causes de-repression of these 























qRT-PCR analysis was performed to examine the expression of Oct4 and Nanog 
throughout the whole neural differentiation course. Data were normalized over the 






2.4.7 The total H1 level progressively increases during neural differentiation 
To ascertain how the H1 level can modulate neural differentiation, we examined 
the expression profiles of H1 variants throughout the course of neural differentiation.  
Total histone extracts from ESCs (day 0), day 8+5, day 8+10, and day 8+15 EBs were 
subjected to HPLC analysis.  Upon neural differentiation, the total H1 level in WT EB 
cultures progressively increased over time, with the total H1/nuc ratio elevated nearly 60% 
from 0.45 in ESCs (day 0) to 0.71 in day 8+15 EB cultures (Figure 2.19).  In contrast, the 
total H1 level was not significantly changed over time in QKO/abi-Dox EBs, remaining 
close to 0.24.  By day 8+15, QKO/abi+Dox EB cultures had an H1/nuc ratio of ~0.17, 
only 24% of that in WT EBs (an H1/nuc ratio of ~0.71). 
During neural differentiation, the increase in the levels of H1c, H1d, H1e, and 
H1
0
 was responsible for the increase in the total H1 level (Figure 2.19).  In H1 TKO EB 
cultures, H1
0
 was dramatically upregulated, accounting for 54% of the total H1 level in 
day 8+15 EBs.  The elevation in the H1
0
 level during neural differentiation is in concert 
with previous findings which suggest an accumulation of H1
0
 in postnatal brain in a 
period corresponding to neural terminal differentiation (Cestelli et al., 1992; Dominguez 
et al., 1992; Pina et al., 1984).  However, H1
0
 alone is not required for neural 
differentiation as shown by the similar extent of neurite formation and comparable 
expression levels of neural markers in H1
0
 KO and WT EBs (Figures 2.20, 2.21, and 
2.22).    
These results indicate that the histone H1 level is progressively increased during 
ESC differentiation and that the severe reduction in total H1 level is responsible for the 




























Figure 2.19 Expression profiles of histone H1 variants during neural differentiation. 
Individual and total H1 to nucleosome ratios were calculated according to HPLC analysis 





























Left panel: percentage of neurite-forming EBs. Numbers were averaged from at least 4 
experiments. Over 100 EBs were counted per experiment. Right panel: numbers of 
neurites per neurite-forming EB. Neurite number was counted from EBs that produced 
neurites. ns: not significant. 
Figure 2.20 H1
0





























TUBB3 was stained in green color and nuclei were counterstained with Hoechst in blue. 
0KO, H1
0
 knockout. Scale bar: 200 μm. 
Day 8+5 and 8+10 EBs were immunostained against the neural stem cell marker Nestin 
(upper panels) and glial cell marker GFAP (lower panels), respectively. Nuclei were 




 knockout alone does not affect TUBB3 expression in day 8+5 EBs. 
Figure 2.22 H1
0






2.4.8 H1d overexpression restores the neural differentiation capacity of ESCs 
To confirm the dosage effect of histone H1 on neural differentiation, we re-
introduced H1d back into QKO/abi ESCs.  H1d overexpression restored the total H1 level 
to 0.43, close to WT ESCs (Figure 2.23).  These ESCs were designated as QKO/abi/H1
res
 
ESCs.  Neural differentiation of QKO/abi/H1
res
 ESCs was performed to examine if H1d 
overexpression could rescue the defects observed in QKO/abi ESCs.  Indeed, over 68% 
of QKO/abi/H1
res
 EBs were able to form neurite outgrowth with an average of 20 neurites 
per EB (Figure 2.24), indicating that QKO/abi/H1
res
 ESCs surpassed H1 TKO ESCs in 
differentiation capacity.  Similarly, the expression of TUBB3, Nestin, and GFAP, and the 
silencing of pluripotency genes, Oct4 and Nanog, were restored in QKO/abi/H1
res
 EB 
cultures (Figures 2.25, 2.26, 2.27, and 2.28).  Collectively, our results reveal a dosage 
effect of histone H1 on neural differentiation of ESCs rather than a variant specificity, 






































HPLC analysis and H1 quantification showed that overexpression of H1d in QKO/abi 
ESCs restored the total H1 level comparable to that in WT ESCs. Values are presented as 
means ± S.D. n = 3. **: p<0.01; ***: p<0.001. 




























A) Phase contrast images of day 8+5 EBs. Scale bar, 200 μm. 
B) Left panel: percentage of neurite-forming EBs. Numbers were averaged from at least 
4 experiments. Over 100 EBs were counted per experiment. Right panel: numbers of 
neurites per neurite-forming EB. Neurite number was counted from EBs that produced 
neurites. Dox was added to media when EB cultures were induced. All data are presented 
as means ± S.D. QKO/abi/H1
res
, H1d overexpression in QKO/abi ESCs. *: p<0.05; ***: 
p<0.001. 
 




























TUBB3 was stained in green color and nuclei counterstained with Hoechst in blue. Scale 
bar: 200 μm. 




























Day 8+5 and 8+10 EBs were immunostained against the neural stem cell marker Nestin 
(upper panels) and the glial cell marker GFAP (lower panels), respectively. Nuclei were 
counterstained with Hoechst in blue color. Scale bar: 20 μm. 
Figure 2.26 H1d overexpression restores the expression of Nestin and GFAP in 
QKO/abi/H1
res




























Figure 2.27 The induction of neural lineage-specific genes in QKO/abi/H1
res
 EB cultures 
during neural differentiation. 
qRT-PCR analysis was performed to examine the expression of the neural stem cell 
marker Nestin, two neuronal markers TUBB3 and tyrosine hydroxylase (TH), and the 
glial marker GFAP in ESCs and differentiating EBs. Data were normalized over the 





























qRT-PCR analysis was performed to examine the expression of Oct4 and Nanog 
throughout the whole neural differentiation course. Data were normalized over the 
expression of GAPDH and are presented as means ± S.D. 
 






2.4.9 Severe H1 depletion causes a reduction in cell proliferation and cellular 
senescence in neural lineages 
While severe H1 depletion did not affect the proliferation of ESCs (Figures 2.2C 
and 2.6C), day 5 EBs with an ultra-low H1 level (QKO/abi+Dox EBs) showed a small 
but statistically significant reduction in EB size (Figure 2.10).  This result suggests that 
fewer cells were present in day 5 ultra-low H1 EBs compared with WT counterparts.  To 
test if cell proliferation is affected in QKO/abi+Dox EBs, we performed 5-bromo-2'-
deoxyuridine (BrdU) incorporation assay in neural lineages.  Day 8+5 EBs were pulsed 
with BrdU for 2 hours and assessed for BrdU incorporation by immunostaining.  WT, H1 
TKO, QKO/abi-Dox, and QKO/abi+Dox EB cultures displayed an increasingly reduced 
level of BrdU incorporation (Figure 2.29).  Quantification of BrdU-positive cells revealed 
47%, 38%, 30%, and 25% of BrdU-positive cells in WT, H1 TKO, QKO/abi-Dox, and 
QKO/abi+Dox EBs, respectively (Figure 2.30).  H1d overexpression was able to rescue 
the defect in cell proliferation (Figures 2.29 and 2.30).  These results establish a dosage 



































Figure 2.30 Quantification of BrdU-positive cells in day 8+5 EB cultures. 
Figure 2.29 H1 depletion leads to a reduction in cell proliferation in neural lineages. 
Day 8+5 EBs were pulsed with BrdU for 2 h and immunostained with an anti-BrdU 
antibody to assess cell proliferation of neural cells. Scale bar: 20 μm. 
Percentages were obtained by counting cells from at least 4 images of BrdU-
immunostained EBs with cell numbers varying from 50 to 90. Data are shown as means 





The observed reduction in cell proliferation after H1 depletion may correspond to 
cellular senescence in neural lineages, a state of irreversible growth arrest (Campisi and 
d'Adda di Fagagna, 2007; Collado et al., 2007).  A previous study suggests that H1 is lost 
in senescent cells, but it is not clear whether H1 loss also has an impact on cellular 
senescence (Funayama et al., 2006).  To compare the level of cellular senescence in ESCs 
and day 8+5 EBs, we performed staining of senescence-associated β-Galactosidase (SA-
β-Gal), a commonly used marker for senescent cells (Dimri et al., 1995).  Although 
sequential H1 depletion did not cause cellular senescence in ESCs (data not shown), it led 
to a progressive increase in SA-β-Gal activity in neural lineages, with the strongest 
staining in QKO/abi+Dox EB cultures (Figure 2.31).  H1d overexpression was able to 
overcome the senescent state.   
Collectively, these results suggest that the loss of histone H1 impairs cell 











Figure 2.31 Severe H1 depletion leads to cellular senescence in differentiating EBs. 
Day 8+5 EBs were stained for senescence-associated β-Galactosidase (SA-β-Gal) 





2.4.10 Oct4 knockdown rescues the defects in neural differentiation caused by H1 
depletion 
As shown earlier, H1 depletion led to dysregulation of pluripotency-associated 
genes during neural differentiation.  To assess whether the effects of H1 depletion on 
neural differentiation is mediated through a lack of Oct4 silencing during differentiation, 
we sought to determine if knockdown of Oct4 expression in QKO/abi EBs is able to 
restore their differentiation.  QKO/abi ESCs were transduced with the Tet-On inducible 
vector encompassing Oct4 shRNAs to establish QKO/abi/Oct4i ESCs.  Upon induction 
with Dox, Oct4 expression in QKO/abi/Oct4i ESCs was depleted to less than 30% of that 
in WT ESCs (Figure 2.32A).  Since Oct4 is an essential transcription factor for ESC self-
renewal and depletion of Oct4 expression impaired cell growth of QKO/abi/Oct4i ESCs, 
we established inducible QKO/abi/Oct4i ESC lines in which knockdown of Oct4 
expression is induced with Dox.  We added Dox at day 5 of EB formation and EBs were 
collected at different time points.  qRT-PCR analysis confirmed that Oct4 expression was 
successfully depleted in QKO/abi/Oct4+Dox EBs during neural differentiation (Figure 
2.32B).  Remarkably, while QKO/abi/Oct4i-Dox EBs resembled QKO/abi-Dox EBs, 
QKO/abi/Oct4i+Dox EBs formed abundant neurites by day 8+5 (Figure 2.33A).  
Quantitatively, 19% QKO/abi/Oct4i-Dox EBs had 9 neurites on average, whereas Oct4 
knockdown restored neurite outgrowth to 67% of EBs with 27 neurites on average 
(Figure 2.33B).  Immunostaining and qRT-PCR analysis of neural markers corroborated 
the efficient rescue of both neurogenic and gliogenic processes (Figures 2.34, 2.35, and 
2.36).  Interestingly, Oct4 knockdown was accompanied by Nanog downregulation 





partially rescue the reduction in cell proliferation and cellular senescence in neural 
lineages, indicating there exist other mechanisms causing these phenomena (Figures 2.37 
and 2.38).  These results demonstrate that Oct4 knockdown alone can efficiently rescue 




















Figure 2.32 Oct4 knockdown in QKO/abi ESCs and EBs. 
QKO/abi ESCs were transduced with pTRIPZ-Oct4shRNA to establish QKO/abi/Oct4i 
ESCs for inducible Oct4 knockdown. Oct4 knockdown efficiency was examined by 




























Figure 2.33 Oct4 knockdown rescues the defects in neurite outgrowth caused by H1 
depletion. 
A) Phase contrast images of day 8+5 EBs. Scale bar: 200 μm.  
B) Left panel: percentage of neurite-forming EBs. Numbers were averaged from at least 
4 experiments. Over 100 EBs were counted per experiment. Right panel: numbers of 
neurites per neurite-forming EB. Neurite number was counted from EBs that produced 




























Figure 2.34 Immunostaining of TUBB3 in day 8+5 QKO/abi/Oct4i EBs. 
TUBB3 was stained in green color and nuclei were counterstained with Hoechst in blue. 




























Figure 2.35 Immunostaining of Nestin and GFAP in QKO/abi/Oct4i EBs. 
Day 8+5 and 8+10 EBs were immunostained against the neural stem cell marker Nestin 
(upper panels) and the glial cell marker GFAP (lower panels), respectively. Nuclei were 




























Figure 2.36 qRT-PCR analysis of the expression of Nanog and neural lineage-specific 
genes in QKO/abi/Oct4i EBs during the whole neural differentiation course. 





























Figure 2.38 Oct4 knockdown partially rescues cellular senescence in differentiating EBs 
caused by H1 depletion. 
Figure 2.37 Oct4 knockdown partially rescues the reduction in cell proliferation in 
neural lineages caused by H1 depletion. 
A) BrdU incorporation assay of day 8+5 QKO/abi/Oct4i EBs. Scale bar: 20 μm. 
B) Quantification of BrdU-positive cells. Percentages were obtained by counting cells 
from at least 4 images of BrdU-immunostained EBs with cell numbers varying from 40 to 
90. Data are shown as means ± S.D. *: p<0.05. 
Day 8+5 QKO/abi/Oct4i EBs were stained for senescence-associated β-Galactosidase 







By sequential depletion of major somatic H1 variants, we took the first step to 
generate a mammalian cellular system with an ultra-low H1 level using combined 
knockout and knockdown approaches.  We first derived H1 QKO ESCs from 
H1c/H1d/H1e/H1
0
 quadruple knockout mouse blastocysts, followed by establishing 
QKO/abi ESCs through knocking down H1a and H1b.  The Tet-On inducible RNAi 
system utilized in this study serves as a convenient and controllable tool for simultaneous 
depletion of the remaining H1a and H1b variants.  This combined approach allowed us to 
deplete the total H1 level in ESCs by 75% (Figure 2.5).  Since ESCs are able to 
differentiate into all cell lineages from three germ layers, the ESC lines generated in this 
study provide great systems to investigate the role of histone H1 in ESC differentiation.  
Surprisingly, Dox-induced QKO/abi ESCs with an H1/nuc ratio of 0.11 have 
normal colony morphology, Oct4 expression, growth rate, and cell cycle profile (Figure 
2.6), indicating that such a minimum level of H1 is compatible with ESC self-renewal.  
Given the presence of remaining 25% histone H1s in these ultra-low H1 ESCs, it remains 
open whether ESCs can self-renew normally in the face of complete loss of all H1s, 
which warrants future studies.  
It is generally accepted that ESCs possess a relatively “open” chromatin state with 
globally transcriptional hyperactivity and undergo chromatin condensation upon 
differentiation (Efroni et al., 2008; Gaspar-Maia et al., 2011).  ESCs have an H1/nuc ratio 
of 0.46 (Fan et al., 2005), approximately 1 H1 per 2 nucleosomes, versus that up to 





and H1e impairs ESC differentiation and disrupts embryonic development (Fan et al., 
2003; Zhang et al., 2012a).  The ultra-low H1 (QKO/abi) ESCs generated here allowed us 
to better examine the role and mechanisms of H1 and chromatin structure in regulating 
ESC differentiation.  Using a neural differentiation protocol that we optimized for 
improved efficiency, we observed a dosage effect of the total histone H1 level, rather 
than a variant specificity, on silencing pluripotency genes and neural differentiation of 
ESCs as well as cell proliferation and senescence in differentiating EBs.  The fact that 
individual deletion of H1
0
, or H1c, or H1d, or H1e, does not affect ESC differentiation 
(this thesis and Zhang et al., 2012b) and that QKO/abi/H1
res
 cells have restored neural 
differentiation further support the dosage effect of somatic H1 variants on neural 
differentiation.  
In contrast to the normal cell proliferation of ultra-low H1 ESCs, EBs exhibit a 
progressive decrease in cell proliferation with an increasing reduction of the total H1 
level as shown in BrdU incorporation assay (Figures 2.29 and 2.30).  Senescence-
associated β-Galactosidase (SA-β-Gal) staining further demonstrated that severe H1 
depletion elicits a cellular senescence state in neural lineages (Figure 2.31).  These results 
suggest that loss of histone H1 impairs cell proliferation and leads to cellular senescence 
in neural lineages.  It would be interesting to examine the chromatin structure and gene 
expression profiles of these cells in differentiating EBs.  Such studies will provide 
insights into how changes in chromatin structure lead to cell cycle defects and cellular 
senescence in differentiated cells.  
The dosage effect of H1 depletion on differentiation is also apparent on the 





differentiation, with more severe defects associated with more severe depletion (Figure 
2.18).  The pluripotency factors orchestrate a regulatory network to govern pluripotency 
and promote self-renewal of ESCs (Liang et al., 2008; Loh et al., 2006; Nichols et al., 
1998; Niwa et al., 2000; Silva et al., 2009).  These pluripotency factors are rapidly 
downregulated upon ESC differentiation and forced expression of Oct4 has been shown 
to block ESC differentiation (Thomson et al., 2011).  To determine if the failure in 
differentiation of ultra-low H1 ESCs is mediated through sustained Oct4 expression, we 
performed inducible Oct4 knockdown in QKO/abi ESCs.  Notably, Oct4 knockdown 
alone in QKO/abi ESCs effectively rescued the defects in neural differentiation in neurite 
formation and the expression of neural markers (Figures 2.33, 2.34, 2.35, and 2.36).  
Knockdown of Oct4 expression in these ultra-low H1 cells also partially restored cell 
proliferation rate and mitigated cellular senescence in EBs (Figures 2.37 and 2.38). 
Sustained Oct4 expression is likely to inhibit lineage-specific expression programs and 
activate genes involved in maintaining stem cell pluripotency.  These results establish 
Oct4 repression by H1 as a critical step and an important mechanism for the role of H1 in 
neural differentiation of ESCs.  
Genome-wide epigenetic profiling studies have revealed that during neural 
differentiation the chromatin in stem cells undergo transition from a highly dynamic state 
to a more restrictive epigenetic landscape that dictates lineage-specific gene expression 
programs (Hawkins et al., 2010; Xie et al., 2013).  Chromatin compaction state is 
dependent on nucleosome repeat length and the stoichiometry of linker histone H1 
(Robinson et al., 2008; Routh et al., 2008).  Our results suggest that chromatin 





The differentiation defects of H1-depleted cells appear to largely result from a failure in 
silencing of Oct4 as shown in the dramatic rescue of the defects in ultra-low H1 EBs by 
knocking down the Oct4 level.  Future studies to compare the gene networks regulated by 
H1 depletion with that by Oct4 knockdown during neural differentiation should lead to 
better understanding of the interplay among regulatory networks controlled by chromatin 
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MUTATION ANALYSIS OF HISTONE H1 
 
The results in chapter 3 have been published in the following article:  
Okosun J, Bödör C, Wang J, Araf S, Yang CY, Pan C, Boller S, Cittaro D, Bozek M, 
Iqbal S, Matthews J, Wrench D, Marzec J, Tawana K, Popov N, O’Riain C, O’Shea D, 
Carlotti E, Davies A, Lawrie CH, Matolcsy A, Calaminici M, Norton A, Byers RJ, Mein 
C, Stupka E, Lister TA, Lenz G, Montoto S, Gribben JG, Fan Y, Grosschedl R, Chelala C, 
Fitzgibbon J. (2014) Integrated genomic analysis identifies recurrent mutations and 




















Follicular lymphoma is an incurable malignancy, with a critical event of 
transformation to an aggressive subtype during disease progression.  Okosun et al. 
performed whole-genome or whole-exome sequencing on 10 follicular lymphoma-
transformed follicular lymphoma pairs and deep sequencing of 28 genes in an extension 
cohort, and reported key genetic events and evolutionary processes driving tumor 
initiation and progression (Okosun et al., 2014).  Interestingly, linker histone H1s are 
among the frequently mutated genes, presenting in 28% of cases.  These mutations are 
clustered in the globular and the C-terminal domains which are directly involved in 
chromatin binding.  To assess the effects and the mechanisms of action of H1 mutations, 
we took advantage of H1c/H1d/H1e triple knockout (H1 TKO) ESCs to test the 
functional difference between wild-type human H1c (WT hH1c) and mutant H1c 
containing the mutation of a.a. 102 from serine to phenylalanine (S102F).  WT hH1c and 
hH1c
S102F
 mutant were introduced into H1 TKO ESCs, and H1 TKO/hH1c and H1 
TKO/hH1c
S102F
 stable clones were screened to identify cell lines expressing similar levels 
of hH1c and hH1c
S102F
 proteins.  HPLC analysis of total histones purified from chromatin 
isolated from these cells indicates that the S102F mutation in hH1c dramatically impairs 
its association with chromatin.  These results suggest that the identified H1 mutations in 
follicular lymphoma most likely lead to a loss-of-function phenotype by reducing the 
binding affinity of H1 for chromatin, thus compromising chromatin compaction and the 








Follicular lymphoma (FL) is the second most frequent lymphoma and the most 
common indolent non-Hodgkin lymphoma (NHL) diagnosed worldwide, comprising 
approximately 35% of all NHLs (The Non-Hodgkin's Lymphoma Classification Project, 
1997).  Although the survival rate of patients with FL has significantly improved during 
the past 25 years through improving treatment regimens and supportive care, FL remains 
an incurable malignancy (Swenson et al., 2005).  As majority of affected patients suffer 
from multiple relapses and eventually develop resistance to standard therapies, follicular 
lymphoma has become a significant clinical burden.  Furthermore, a subgroup of patients 
undergo transformation into the more aggressive diffuse large B cell lymphoma 
(DLBCL), which results in poor clinical outcome and shortens patients’ survival (Al-
Tourah et al., 2008; Montoto et al., 2007; Montoto and Fitzgibbon, 2011).  
 Tumor cells in FL are malignant transformation of normal germinal center B cells.  
The chromosomal translocation of t(14;18)(q32:q21) with rearrangement of the BCL2 
gene in juxtaposition to the immunoglobulin heavy chain promoter, represents 85 - 90% 
of cases (Weiss et al., 1987; Zelenetz et al., 1991).  This genetic aberration leads to 
constitutive expression of BCL2 and confers a survival advantage to B cells, thus playing 
a critical role in pathogenesis of FL.  However, this translocation alone is considered to 
be necessary but insufficient for the initiation of FL.  Other than BCL2, mutations in 
multiple genes involved in B cell development, immune response, and epigenetic 
regulation have been identified, including TNFRSF14 (Cheung et al., 2010; Launay et al., 





al., 2011), and genes encoding histone methyltransferases, MLL2 (Morin et al., 2011) and 
EZH2 (Kridel et al., 2012; Morin et al., 2010).   
Our understanding in the pathology of FL has been greatly advanced by recent 
genomic sequencing and case studies which suggest successive disease events occur from 
a long-existing tumor-initiating progenitor cell compartment (Carlotti et al., 2009; Eide et 
al., 2010; Ruminy et al., 2008; Weigert et al., 2012).  An in-depth characterization and 
chronicling of the underlying genetic alterations in FL transformation will provide 
guidance in developing targeting therapeutic strategies.  Okosun et al. performed whole-
genome or whole-exome sequencing of follicular lymphoma - transformed follicular 
lymphoma (FL-tFL) pairs in match with germline samples from 10 cases (Okosun et al., 
2014).  The integrated genomic analysis identified key events and evolutionary processes 
governing the initiation and the transformation of FL, which are confined to recurrent 
mutations in 28 genes involved in epigenetic regulations, immune response, JAK-STAT 
signaling, NF-κB signaling, and B cell development (Okosun et al., 2014).  Interestingly, 
28% of cases were found to contain mutations in at least one histone H1 gene, and 
HIST1H1C and HIST1H1E (genes encoding H1c and H1e variants respectively) are the 
most frequently mutated (Okosun et al., 2014).   
Given that histone H1 is a key component of higher order chromatin structure and 
regulates specific gene expression, it is not surprising to discover the involvement of 
histone H1 in tumorigenesis.  Expression profiling of histone H1 variants in ovarian 
cancer shows that ovarian adenocarcinomas and adenomas exhibit distinct expression 
patterns of the somatic H1 genes, which indicates the expression patterns of histone H1 





In addition, frequent mutations in HIST1H1B and HST1H1E genes have been identified 
in colorectal cancer through genome-wide analysis (Sjoblom et al., 2006; Wood et al., 
2007).  Recurrent missense mutations in multiple somatic H1 variants have also been 
found in follicular lymphoma in similar studies (Li et al., 2014; Lohr et al., 2012; Morin 
et al., 2011; Okosun et al., 2014).  However, it is still unclear how these mutations of 
histone H1 affect their in vivo functions and contribute to tumorigenesis.  To address this 














3.3 Materials and Methods 
 
3.3.1 Cell culture 
 ESCs were propagated on mitotically inactivated mouse embryonic fibroblast 
feeder layers in tissue culture dishes (Corning) coated with 0.1% gelatin (Sigma-Aldrich).  
Prior to HPLC analysis, ESCs were grown on feeder-free culture dishes for feeder 
removal.  ESC culture media consisted of Dulbecco's modified Eagle's medium (DMEM) 
(Life Technologies) supplemented with 15% fetal bovine serum (FBS) (Gemini), 100 
U/ml penicillin (Life Technologies), 100 μg/ml streptomycin (Life Technologies), 1X 
MEM nonessential amino acids (Life Technologies), 0.1 mM β-mercaptoethanol (Life 
Technologies), and 103 U/ml of leukemia inhibitory factor (LIF; ESGRO, Chemicon).  
Cultures were re-fed with fresh media every other day, and passaged every 2-3 days 
when reaching 70-80% confluence.   
 
3.3.2 Generation of hH1c and hH1c
S102F
 expressing ESC lines from H1c/H1d/H1e 
triple knockout ESCs 
A point mutation (C305T) in WT hH1c coding region was made using 
QuikChange II Site-Directed Mutagenesis Kit (Stratagene) following the manufacturer’s 
manual, resulting in Ser102Phe (S102F) mutation in hH1c protein present in follicular 
lymphoma.  To facilitate the screening of ESC clones expressing the WT hH1c or the 
hH1c
S102F
 mutant, we inserted the FLAG tag sequence at the N-terminus of WT and 
mutant hH1c genes, allowing Western blotting analysis to quantify the expression levels 
of hH1c or hH1c
S102F





the N-terminal FLAG epitope does not change the biochemical properties or in vivo 
functions of H1 variants (Cao et al., 2013).  FLAG-hH1c or FLAG-hH1c
S102F
 was 
subsequently inserted into an expression vector containing 5 kb mouse H1d upstream and 
downstream regulatory regions and the blasticidin resistant gene established previously 
(Zhang et al., 2012).  20 μg of plasmid DNA was transfected into 2 x 10
7
 H1 TKO ESCs 
by electroporation and a total of 24 clones resistant to blasticidin (Life Technologies) 
were picked for each construct and screened by Western blotting against the FLAG 
epitope (Sigma-Aldrich, F1804).  ESC clones with similar expression levels of the 
respective FLAG-hH1c and FLAG-hH1c
S102F
 were selected for subsequent analyses. 
 
3.3.3 Histone extraction and HPLC analysis 
ESC chromatin was prepared and histones were extracted from H1 TKO/hH1c 
and H1 TKO/hH1c
S102F
 ESCs with 0.2 N sulfuric acid (H2SO4) according to protocols 
described previously (Cao et al., 2013; Fan and Skoultchi, 2004; Medrzycki et al., 2012a).  
Approximately 50 μg of total histones were injected into a C18 reverse phase column 
(Vydac) on an Äktapurifier UPC 900 system (GE Healthcare).  Linker histones and core 
histones were fractionated with an increasing acetonitrile gradient (Medrzycki et al., 
2012a).  The effluent was monitored at 214 nm, and the peak areas were analyzed with 
AKTA UNICORN 5.11 software (GE Healthcare).  The areas of A214 peaks of H1 
variants and H2B were normalized by the number of peptide bonds of respective histone 
proteins, and the normalized values were used for calculation of H1 to nucleosome 








3.4.1 Examination of H1 mutations identified in follicular lymphoma 
Through genomic and exomic sequencing on follicular lymphoma-transformed 
follicular lymphoma (FL-tFL) pairs followed by deep sequencing of target genes, Okosun 
et al. identified fifty-five mutations across linker histone variants, HIST1H1B - 
HIST1H1E in 38 patients (29 diagnostic/relapse cases; 9 cases with paired FL-tFL 
biopsies) (Okosun et al., 2014).  Mutations in HIST1H1E and HIST1H1C were most 
frequently observed (30 mutations in 23 cases and 12 mutations in 10 cases, respectively).  
Overall, 28% of the cohort tested had mutations in at least one H1 gene.  Sequence 
alignment of H1 variants and the globular domain of avian H5 (Ramakrishnan et al., 1993) 
indicated that vast majority of mutations are clustered within the C-terminal domain and 
the highly conserved globular domain directly involved in DNA binding and chromatin 
compaction (Brown et al., 2006; Goytisolo et al., 1996; Vyas and Brown, 2012) (Figure 
3.1).  Therefore, these mutations may change the binding affinity and residence time of 
the respective H1 variants in chromatin and compromise their functions in chromatin 































3.4.2 Mutation analysis of the human H1c
S102F
 mutation 
To ascertain the mechanisms of action of these mutations, we took advantage of 
H1c/H1d/H1e null ESCs (Fan et al., 2005) to characterize the recurrent mutations in 
human H1 proteins.  We started with the S102F mutation in hH1c.  H1 TKO ESCs, 
lacking the endogenous H1c, H1d, and H1e, provide a clean cellular system for us to 
compare the differences between the hH1 mutants and their wild-type counterparts in 
chromatin binding.  Expression vectors containing the FLAG-tagged WT hH1c or 
hH1c
S102F
 mutant were constructed and transfected into H1 TKO ESCs and screened by 
Western blotting for stable cell lines with high expression of the transfected H1 genes 
(Figure 3.2A).  We have shown previously that N-terminal FLAG tag does not change the 
biochemical properties or in vivo functions of H1 variants (Cao et al., 2013).  Thus, we 
were able to screen different cell clones with semi-quantitative Western blotting using 
anti-FLAG antibodies to isolate the cell lines with equal expression levels of respective 
FLAG-hH1c and FLAG-hH1c
S102F















A) Expression of FLAG tagged human H1c (hH1c) or hH1c
S102F
 mutant in H1c/H1d/H1e 
triple null embryonic stem cells (H1 TKO ESCs). H1 TKO ESCs were transfected with 
vectors expressing FLAG-hH1c or FLAG-hH1c
S102F
 mutant. Twenty-four stable ESC 
clones were picked for each transfection and screened using an anti-FLAG antibody. 
Representative immunoblots of FLAG-hH1c or FLAG-hH1c
S102F
 expressing cell clones 
are shown. Immunoblots with anti-β-actin antibody were included as loading controls. 
Clones indicated with asterisks, demonstrating high expression levels of hH1c or 
hH1c
S102F
 were used in subsequent analysis. 
B) FLAG-hH1c and FLAG-hH1c
S102F
 are expressed at the same levels in selected clones 





Next, we purified the chromatin of H1 TKO/hH1c and H1 TKO/hH1c
S102F
 ESC 
lines, extracted total histones from chromatin, and performed reserve-phase HPLC (RP-
HPLC) analysis of the histone extracts.  The overexpressed FLAG-hH1c and FLAG-
hH1c
S102F
 eluted in separate peaks on HPLC profiles with a delay in elusion time for the 
FLAG-hH1c
S102F
 peak, indicating a higher hydrophobicity of FLAG-hH1c
S102F
 than 
FLAG-hH1c (Figure 3.3A).  Quantification of individual H1/nucleosome ratios showed a 
much lower level of chromatin bound FLAG-hH1c
S102F
 (0.046) than that of FLAG-hH1c 
(0.13), resulting in lack of significant increase in the total H1 level in H1 TKO/hH1c
S102F
 
ESCs compared with H1 TKO ESCs (Figure 3.3B).  These results suggest that, despite an 
equal expression level as hH1c, hH1c
S102F
 has drastically reduced binding affinity for 
DNA and residence time in chromatin, most likely owing to the change in the 
biochemical property and the interference of DNA binding caused by the mutation.  The 
other H1 TKO/hH1c
S102F
 clone also displayed similar low abundance in chromatin 



















Figure 3.3 Reverse-phase HPLC (RP-HPLC) analysis of mouse H1 TKO ESCs 










A) RP-HPLC profiles of histones extracted from chromatin isolated from histone H1 
triple-knockout (TKO) mouse ESCs expressing wild-type or S102F human histone H1. 
The S102F mutant demonstrated higher hydrophobicity than the wild-type protein. mH1a, 
mouse histone H1a; mH1b, mouse histone H1b; mH2b, mouse histone H2b; hH1c, human 
histone H1c. 
B) Ratio of individual histone H1 variants (and total histone H1) to the nucleosome of the 
indicated ESC lines. The ratio is calculated from the HPLC analysis in (A) and 
demonstrates that the total histone H1 levels in histone H1 triple-knockout ESCs 
expressing human histone H1c
S102F
 were reduced compared to cells expressing wild-type 
human histone H1c, as a result of the weaker association of the mutant histone with 







In the current study, Okosun et al. reported a comprehensive sequencing effort to 
identify genetic alterations promoting the initiation and progression of FL (Okosun et al., 
2014).  This work identified a significant role of epigenetic changes in FL, as well as 
other co-occurring aberrations in JAK-STAT and NF-κB signaling.  
Surprisingly, histone H1 was found to be recurrently mutated in FL, highlighting 
the potential contribution of higher order chromatin folding in FL tumorigenesis.  The 
mutations are concentrated in the globular and the C-terminal domains normally involved 
in DNA binding (Brown et al., 2006; Goytisolo et al., 1996; Vyas and Brown, 2012).  
Indeed, the hH1c
S102F
 mutant displays reduced binding to chromatin, suggesting a loss of 
function mutation.  Other H1 mutations may cause a similar loss-of-function effect as the 
hH1c
S102F
 analyzed here.  Interestingly, many mutations occurred in nonpolar (e.g. 
alanine and valine) or uncharged (e.g. serine and proline) a.a. residues, which may not 
directly interact with the negatively charged DNA (Goytisolo et al., 1996; Ramakrishnan 
et al., 1993).  However, these residues are conserved among paralogs, suggesting that 
they may have important functions in maintaining the protein structure for basic residues 
to interact with DNA.  hH1c
S102F
 may have a different structure leading to its defect in 
chromatin binding and/or alteration in its genomic localization patterns.  It would also be 
interesting to tease out how H1 mutations affect gene regulation in follicular lymphoma.  
Other mutations distribute across the intrinsically disordered C-terminal domain, which 
binds to linker DNA and is important for chromatin condensation (Hansen et al., 2006; 





variants may also disrupt the interaction of the respective H1 variant with other specific 
protein binding partners (McBryant et al., 2010).  Further studies along these lines shall 
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CONCLUSIONS AND FUTURE STUDIES 
 
Linker histone H1 and H1 variants play key roles in facilitating chromatin 
packaging into higher order structures.  In this study, we first generated ultra-low H1 
ESCs by deriving H1c/H1d/H1e/H1
0
 quadruple knockout ESCs (H1 QKO ESCs) using 
mouse genetics followed by depletion of H1a and H1b in H1 QKO ESCs using a Tet-On 
inducible RNAi system.  We adopted this approach to avoid the potential deleterious 
effects of the minimum H1 level on ESC viability.  However, these ESCs, with an 
H1/nuc ratio as low as 0.11, exhibit normal colony morphology and proliferation rates, 
indicating that severe depletion of the H1 level is compatible with ESC self-renewal.  
Given the viability of these ESCs, future studies aim to generate complete H1 null ESCs 
using genome-editing tools such as CRISPR/Cas- and TALEN- based methods (Cong et 
al., 2013; Gaj et al., 2013; Mali et al., 2013; Miller et al., 2011) should be feasible.  Such 
experiments will address if there is a minimum threshold of H1 required for ESC self-
renewal.  
The work in this thesis demonstrated a dosage effect of histone H1 on neural 
differentiation of ESCs.  Neural differentiation gives rise to neural progenitors and 
defined neural lineages which display distinct cell shapes and express multiple specific 
markers (Bibel et al., 2004; Doetsch, 2003; Temple, 2001; Zhang et al., 2001), rendering 
an ideal approach to study the regulatory mechanisms of ESC differentiation.  In vitro 
neural differentiation of ESCs with sequential H1 depletion revealed a dosage effect, 





neurons, and glial cells, representing all major events during neurodevelopment.  The 
dosage effect is also apparent in silencing pluripotency-associated genes which are 
normally rapidly downregulated upon ESC differentiation.  Since the H1 content 
gradually increases during neural differentiation, we surmise that chromatin condensation 
mediated by H1 plays a fundamental role in Oct4 silencing, which in turn serves as a 
critical step for differentiation to proceed successfully.  It is likely that, despite a global 
effect on chromatin compaction, H1 acts locally at key regulatory loci in modulating cell 
differentiation.   
While ESC self-renewal appears unaffected by low H1 content, we found that 
severe H1 depletion leads to reduced cell proliferation and cellular senescence in 
differentiating EBs.  A previous report shows impaired cell proliferation in chicken 
lymphocytes with complete H1 knockout (Hashimoto et al., 2010).  Together, these 
studies suggest that H1 is important for the propagation of differentiated cells, which 
have a much higher H1 content than ESCs.  It has also been shown that depletion of 
certain specific H1 variants induces cell cycle arrest and cellular senescence in human 
breast cancer cells and fibroblasts (Funayama et al., 2006; Sancho et al., 2008), 
suggesting potential specificities of H1 variants in cell cycle regulation in different 
cellular context.  Future studies on the molecular mechanisms underlying the cell 
proliferation defects in differentiated cells upon H1 depletion will illuminate how H1 and 
higher order chromatin structure are connected to cell cycle progression and cellular 
senescence.  For example, one potential mechanism to investigate is the DNA damage 
response in differentiating QKO/abi cells.  DNA damage responses elicit DNA repair and 





lymphocytes leads to increased chromosome aberration rates (Hashimoto et al., 2010).  
Immunostaining of γ-H2AX (Ser139 phosphorylated H2AX), a biomarker for double-
strand breaks (Burma et al., 2001; Dickey et al., 2009; Rogakou et al., 1998), can be used 
to compare DNA lesions in QKO/abi and WT EBs.  
Another key finding of this study is that Oct4 knockdown effectively restores 
neural differentiation and partially reverses the reduction in cell proliferation and cellular 
senescence in QKO/abi EBs.  Other factors that may rescue neural differentiation in the 
context of H1 loss remain to be identified.  Beside Oct4 and Nanog, the expression of 
other pluripotency-associated factors, such as Sox2, Sall4, Dax1, Essrb, Tbx3, Tcl1, Rif1, 
Nac1, and Zfp281 (Chen and Daley, 2008; Ivanova et al., 2006; Ng and Surani, 2011; 
Wang et al., 2006) may also be affected by H1 loss.  These factors regulate each other to 
form a complex transcriptional regulatory network in promoting ESC self-renewal (Zhou 
et al., 2007).  In addition to pluripotency factors, neurogenic factors controlling lineage 
commitment including Pax6, Ascl1, Brn2, Ngn2, and Mytl1 (Hsieh, 2012; Kohwi and 
Doe, 2013; Zhang et al., 2013) may also be dysregulated upon H1 depletion.  Expression 
profiling of QKO/abi and WT cells should offer a better picture of the scope of H1’s 
regulation on pluripotency genes and lineage-specific genes.  Whether overexpression of 
the neurogenic factors could rescue the defects in neural differentiation of ESCs with low 
H1 levels is also warranted.   
 A separate addition to my thesis work is the mutation analysis of H1 mutants 
identified in Follicular lymphoma (FL), the most common indolent non-Hodgkin 
lymphoma of significant clinical burden.  Through whole-genome or whole-exome 





Lab identified recurrent mutations driving the initiation and progression of FL (Okosun et 
al., 2014).  Among the frequent mutations are linker histone H1 variants, with their 
mutations present in 28% of cases, and HIST1H1C and HIST1H1E were the most 
frequently mutated.  Majority of the mutations are concentrated to the conserved globular 
domain and the intrinsically disordered C-terminus, which are essential for binding of H1 
to chromatin.  Mutation analysis of hH1c
S102F
 demonstrated that this mutation increases 
hH1c’s hydrophobicity and reduces its binding affinity for chromatin, thus likely acts 
through a loss-of-function mechanism by compromising hH1c’s functions in chromatin 
compaction and regulation of key genes, contributing to malignant transformation of B 
lymphocytes.  Future studies to characterize mutations of other sites and variants will 
provide a more comprehensive picture about the impact of H1 mutations.  It will also be 
worthwhile to investigate how H1 mutations affect gene regulation in B cells for better 







Bibel, M., Richter, J., Schrenk, K., Tucker, K.L., Staiger, V., Korte, M., Goetz, M., and 
Barde, Y.A. (2004). Differentiation of mouse embryonic stem cells into a defined 
neuronal lineage. Nature neuroscience 7, 1003-1009. 
Burma, S., Chen, B.P., Murphy, M., Kurimasa, A., and Chen, D.J. (2001). ATM 
phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 
276, 42462-42467. 
Chen, L., and Daley, G.Q. (2008). Molecular basis of pluripotency. Hum Mol Genet 17, 
R23-27. 
Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, 
W., Marraffini, L.A., et al. (2013). Multiplex genome engineering using CRISPR/Cas 
systems. Science 339, 819-823. 
Dickey, J.S., Redon, C.E., Nakamura, A.J., Baird, B.J., Sedelnikova, O.A., and Bonner, 
W.M. (2009). H2AX: functional roles and potential applications. Chromosoma 118, 683-
692. 
Doetsch, F. (2003). The glial identity of neural stem cells. Nature neuroscience 6, 1127-
1134. 
Funayama, R., Saito, M., Tanobe, H., and Ishikawa, F. (2006). Loss of linker histone H1 
in cellular senescence. J Cell Biol 175, 869-880. 
Gaj, T., Gersbach, C.A., and Barbas, C.F., 3rd (2013). ZFN, TALEN, and CRISPR/Cas-
based methods for genome engineering. Trends in biotechnology 31, 397-405. 
Hashimoto, H., Takami, Y., Sonoda, E., Iwasaki, T., Iwano, H., Tachibana, M., Takeda, 
S., Nakayama, T., Kimura, H., and Shinkai, Y. (2010). Histone H1 null vertebrate cells 
exhibit altered nucleosome architecture. Nucleic Acids Res 38, 3533-3545. 
Hsieh, J. (2012). Orchestrating transcriptional control of adult neurogenesis. Genes Dev 
26, 1010-1021. 
Ivanova, N., Dobrin, R., Lu, R., Kotenko, I., Levorse, J., DeCoste, C., Schafer, X., Lun, 
Y., and Lemischka, I.R. (2006). Dissecting self-renewal in stem cells with RNA 
interference. Nature 442, 533-538. 
Kohwi, M., and Doe, C.Q. (2013). Temporal fate specification and neural progenitor 





Lukas, J., Lukas, C., and Bartek, J. (2011). More than just a focus: The chromatin 
response to DNA damage and its role in genome integrity maintenance. Nat Cell Biol 13, 
1161-1169. 
Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E., and 
Church, G.M. (2013). RNA-guided human genome engineering via Cas9. Science 339, 
823-826. 
Miller, J.C., Tan, S., Qiao, G., Barlow, K.A., Wang, J., Xia, D.F., Meng, X., Paschon, 
D.E., Leung, E., Hinkley, S.J., et al. (2011). A TALE nuclease architecture for efficient 
genome editing. Nat Biotechnol 29, 143-148. 
Ng, H.H., and Surani, M.A. (2011). The transcriptional and signalling networks of 
pluripotency. Nat Cell Biol 13, 490-496. 
Okosun, J., Bodor, C., Wang, J., Araf, S., Yang, C.Y., Pan, C., Boller, S., Cittaro, D., 
Bozek, M., Iqbal, S., et al. (2014). Integrated genomic analysis identifies recurrent 
mutations and evolution patterns driving the initiation and progression of follicular 
lymphoma. Nat Genet 46, 176-181. 
Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S., and Bonner, W.M. (1998). DNA 
double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol 
Chem 273, 5858-5868. 
Sancho, M., Diani, E., Beato, M., and Jordan, A. (2008). Depletion of human histone H1 
variants uncovers specific roles in gene expression and cell growth. PLoS Genet 4, 
e1000227. 
Temple, S. (2001). The development of neural stem cells. Nature 414, 112-117. 
Wang, J., Rao, S., Chu, J., Shen, X., Levasseur, D.N., Theunissen, T.W., and Orkin, S.H. 
(2006). A protein interaction network for pluripotency of embryonic stem cells. Nature 
444, 364-368. 
Zhang, S.C., Wernig, M., Duncan, I.D., Brustle, O., and Thomson, J.A. (2001). In vitro 
differentiation of transplantable neural precursors from human embryonic stem cells. Nat 
Biotechnol 19, 1129-1133. 
Zhang, Y., Schulz, V.P., Reed, B.D., Wang, Z., Pan, X., Mariani, J., Euskirchen, G., 
Snyder, M.P., Vaccarino, F.M., Ivanova, N., et al. (2013). Functional genomic screen of 
human stem cell differentiation reveals pathways involved in neurodevelopment and 
neurodegeneration. Proc Natl Acad Sci U S A 110, 12361-12366. 
Zhou, Q., Chipperfield, H., Melton, D.A., and Wong, W.H. (2007). A gene regulatory 
network in mouse embryonic stem cells. Proc Natl Acad Sci U S A 104, 16438-16443. 
 
